Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Abortion, Habitual
Paraoxonase-1 Polymorphisms (L55M/Q192R) and Activities (PONase/AREase) in Patients with Idiopathic Recurrent Early Pregnancy Loss: A Preliminary Study.
Abortion, Spontaneous
Paraoxonase-1 Polymorphisms (L55M/Q192R) and Activities (PONase/AREase) in Patients with Idiopathic Recurrent Early Pregnancy Loss: A Preliminary Study.
Acne Vulgaris
Oral isotretinoin therapy of acne patients decreases serum paraoxonase-1 activity through increasing oxidative stress.
Acromegaly
Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly.
Acute Coronary Syndrome
Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome.
Acute Coronary Syndrome
Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.
Acute Coronary Syndrome
Association between paraoxonase 1 activity and severity of coronary artery disease in patients with acute coronary syndromes.
Acute Coronary Syndrome
Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk.
Acute Coronary Syndrome
Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome.
Acute Coronary Syndrome
Influence of high-density lipoprotein and paraoxonase-1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapy.
Acute Coronary Syndrome
Lack of association between serum paraoxonase-1 activity and residual platelet aggregation during dual anti-platelet therapy.
Acute Coronary Syndrome
Oxidation and endothelial dysfunction biomarkers of atherosclerotic plaque instability. Studies of the vascular wall and blood.
Acute Coronary Syndrome
Serum arylesterase activity is negatively correlated with inflammatory markers in patients with acute coronary syndromes.
Acute Coronary Syndrome
[Association between paraoxonase concentration and risk of acute coronary syndrome].
Acute Kidney Injury
Association of paraoxonase 1 and oxidative stress with acute kidney injury in premature asphyxiated neonates.
Acute Kidney Injury
Effect of continuous renal-replacement therapy on paraoxonase-1-related variables in patients with acute renal failure caused by septic shock.
Adenocarcinoma
Adenocarcinoma of the colon with choriocarcinoma in its metastases.
Adrenocortical Hyperfunction
Serum paraoxonase 1 and butyrylcholinesterase in dogs with hyperadrenocorticism.
alcohol dehydrogenase deficiency
Ecogenetic and pharmacogenetic studies in Hungary.
alcohol dehydrogenase deficiency
Ecogenetic studies in Atacameño Indians.
Alopecia Areata
Evaluation of Serum Paraoxonase, Arylesterase, Prolidase Activities and Oxidative Stress in Patients with Alopecia Areata.
Alzheimer Disease
A Meta-Analysis on the Relationship of the PON Genes and Alzheimer Disease.
Alzheimer Disease
Alzheimer's Disease and Paraoxonase 1 (PON1) Gene Polymorphisms.
Alzheimer Disease
Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia.
Alzheimer Disease
Assessment of Paraoxonase 1 Activity in Patients With Alzheimer's Disease and Vascular Dementia.
Alzheimer Disease
Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
Alzheimer Disease
Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.
Alzheimer Disease
Association study of the paraoxonase 1 gene with the risk of developing Alzheimer's disease.
Alzheimer Disease
Codon 311 (Cys --> Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias.
Alzheimer Disease
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
Alzheimer Disease
Different pattern of association of paraoxonase Gln192-->Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease.
Alzheimer Disease
Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development.
Alzheimer Disease
Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia.
Alzheimer Disease
Gln192Arg polymorphism in paraoxonase 1 gene is associated with Alzheimer disease in a Chinese Han ethnic population.
Alzheimer Disease
Higher Levels of Oxidized Low Density Lipoproteins in Alzheimer's Disease Patients: Roles for Platelet Activating Factor Acetyl Hydrolase and Paraoxonase-1.
Alzheimer Disease
Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology.
Alzheimer Disease
Lack of an association between Paraoxonase 1 gene polymorphisms (Q192R, L55M) and Alzheimer's disease: A meta-analysis.
Alzheimer Disease
No association of paraoxonase gene polymorphism with atherosclerosis or Alzheimer's disease.
Alzheimer Disease
Normalization of gene expression using SYBR green qPCR: A case for paraoxonase 1 and 2 in Alzheimer's disease brains.
Alzheimer Disease
Paraoxonase 1 (PON1) gene -108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia.
Alzheimer Disease
Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease.
Alzheimer Disease
Paraoxonase 1 decline and lipid peroxidation rise reflect a degree of brain atrophy and vascular impairment in dementia.
Alzheimer Disease
Paraoxonase 1 Gene Polymorphisms Do Not Influence the Response to Treatment in Alzheimer's Disease.
Alzheimer Disease
Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment.
Alzheimer Disease
Paraoxonase activity and dementia.
Alzheimer Disease
Paraoxonase gene polymorphism and the risk for Alzheimer's disease in the polish population.
Alzheimer Disease
Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer's Disease.
Alzheimer Disease
Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD-PD spectrum diseases.
Alzheimer Disease
Polymorphisms at the paraoxonase 1 L55M and Q192R loci affect the pathophysiology of Alzheimer's disease: emphasis on the cholinergic system and beta-amyloid levels.
Alzheimer Disease
Polymorphisms in the PON gene cluster are associated with Alzheimer disease.
Alzheimer Disease
Possible association between Cys311Ser polymorphism of paraoxonase 2 gene and late-onset Alzheimer's disease in Chinese.
Alzheimer Disease
Profile of the Paraoxonase 1 (PON1) Gene 192Q/R Polymorphism and Clinical Associations among Older Singaporean Chinese with Alzheimer's and Mixed Dementia.
Alzheimer Disease
Serum HDL Associated Antioxidant Activity in Alzheimer's Disease: Paraoxonase1 and Dysfunctional HDL.
Alzheimer Disease
Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
Alzheimer Disease
Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease.
Alzheimer Disease
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study.
Alzheimer Disease
Synergistic Epistasis of Paraoxonase 1 (rs662 and rs85460) and Apolipoprotein E4 Genes in Pathogenesis of Alzheimer's Disease and Vascular Dementia.
Alzheimer Disease
Urinary 8-hydroxy-2'-deoxyguanosine level and plasma paraoxonase 1 activity with Alzheimer's disease.
Alzheimer Disease
[Gln192Arg polymorphism of the paraoxonase-1 gene is not associated with Alzheimer's disease in Chinese]
Alzheimer Disease
[Paraoxonase 1 gene Gln192Arg polymorphism in and Alzheimer disease]
Amyloidosis
Serum esterase activity in reactive systemic amyloidosis and its relation to amyloid A degrading activity.
Amyotrophic Lateral Sclerosis
A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS.
Amyotrophic Lateral Sclerosis
Association analysis of PON polymorphisms in sporadic ALS in a Chinese population.
Amyotrophic Lateral Sclerosis
Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden.
Amyotrophic Lateral Sclerosis
Interaction between PON1 and population density in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Lack of association of PON polymorphisms with sporadic ALS in an Italian population.
Amyotrophic Lateral Sclerosis
Motor neuron diseases and neurotoxic substances: a possible link?
Amyotrophic Lateral Sclerosis
Neuropathy target esterase gene mutations cause motor neuron disease.
Amyotrophic Lateral Sclerosis
Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
Amyotrophic Lateral Sclerosis
Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis.
Amyotrophic Lateral Sclerosis
Paraoxonase gene mutations in amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Paraoxonase-1 Q192R polymorphism and risk of sporadic amyotrophic lateral sclerosis.
Amyotrophic Lateral Sclerosis
Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients.
Anemia
Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Anemia
Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Anemia
Comparison of serum paraoxonase and arylesterase activities between iron deficiency anemia patients and chronic kidney disease patients with anemia.
Anemia
Effects of Iron Supplementation With and Without Docosahexaenoic Acid on the Cardiovascular Disease Risk Based on Paraoxonase-1, hs-CRP, and ApoB/ApoA-I Ratio in Women with Iron Deficiency Anemia.
Anemia
Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes - connection with inflammation.
Anemia
Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia.
Anemia
Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major.
Anemia
Reduced antioxidant capacity in children with iron deficiency and iron-deficiency anemia.
Anemia
Serum paraoxonase 1 activity in patients with iron deficiency anemia.
Anemia, Iron-Deficiency
Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Anemia, Iron-Deficiency
Comparison of serum paraoxonase and arylesterase activities between iron deficiency anemia patients and chronic kidney disease patients with anemia.
Anemia, Iron-Deficiency
Effects of Iron Supplementation With and Without Docosahexaenoic Acid on the Cardiovascular Disease Risk Based on Paraoxonase-1, hs-CRP, and ApoB/ApoA-I Ratio in Women with Iron Deficiency Anemia.
Anemia, Iron-Deficiency
Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia.
Anemia, Iron-Deficiency
Serum paraoxonase 1 activity in patients with iron deficiency anemia.
Anemia, Sickle Cell
Paraoxonases (PON) 1, 2, and 3 Polymorphisms and PON-1 Activities in Patients with Sickle Cell Disease.
Angina Pectoris
Pro-inflammatory Mediators and Oxidative Stress: Therapeutic Markers for Recurrent Angina Pectoris after Coronary Artery Stenting in Elderly Patients.
Anovulation
Estimation of gene-environment interaction by pooling biospecimens.
Anthrax
Serum paraoxonase activity and oxidative stress levels in patients with cutaneous anthrax.
Antiphospholipid Syndrome
Antibodies against beta(2)-glycoprotein I complexed with an oxidised lipoprotein relate to intima thickening of carotid arteries in primary antiphospholipid syndrome.
Antiphospholipid Syndrome
Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
Antiphospholipid Syndrome
Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.
Antiphospholipid Syndrome
Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome.
Aortic Aneurysm, Abdominal
Paraoxonase-1 overexpression prevents experimental abdominal aortic aneurysm progression.
Aortic Aneurysm, Abdominal
The Paraoxonase Gene Cluster Protects Against Abdominal Aortic Aneurysm Formation.
Aortic Valve Insufficiency
Decreased paraoxonase 1, arylesterase enzyme activity, and enhanced oxidative stress in patients with mitral and aortic valve insufficiency.
Aortic Valve Stenosis
Expression levels of paraoxonase-1 in aortic valve tissue are associated with the progression of calcific aortic valve stenosis.
Aortic Valve Stenosis
Functional SNP in the 3'UTR of PON1 is Associated with the Risk of Calcific Aortic Valve Stenosis via MiR-616.
Aortic Valve Stenosis
Paraoxonase activity might be predictive of the severity of aortic valve stenosis.
Appendicitis
Total oxidant status, total antioxidant status, and paraoxonase activity in acute appendicitis.
Arteriosclerosis
Antioxidant and anti-inflammatory role of paraoxonase 1: implication in arteriosclerosis diseases.
Arteriosclerosis
Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities.
Arthritis
Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis.
Arthritis, Psoriatic
HDL associated paraoxonase-1 activity correlates with systemic inflammation, disease activity and cardiovascular risk factors in psoriatic disease.
Arthritis, Rheumatoid
Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis.
Arthritis, Rheumatoid
Antibodies to paraoxonase 1 are associated with oxidant status and endothelial activation in rheumatoid arthritis.
Arthritis, Rheumatoid
Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Association between activity and genotypes of paraoxonase1 L55M (rs854560) increases the disease activity of rheumatoid arthritis through oxidative stress.
Arthritis, Rheumatoid
Association of Paraoxonase 1 gene polymorphisms and enzyme activity with carotid plaque in rheumatoid arthritis.
Arthritis, Rheumatoid
Association of Paraoxonase 1 Polymorphism and Serum 25-Hydroxyvitamin D with the Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis.
Arthritis, Rheumatoid
Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis.
Arthritis, Rheumatoid
Beta-Carotene, Vitamin E, MDA, Glutathione Reductase and Arylesterase Activity Levels in Patients with Active Rheumatoid Arthritis.
Arthritis, Rheumatoid
Effect of Fish Oil Supplements on Serum Paraoxonase Activity in Female Patients with Rheumatoid Arthritis: A Double-blind Randomized Controlled Trial.
Arthritis, Rheumatoid
Functional implications of single nucleotide polymorphisms rs662 and rs854860 on the antioxidative activity of paraoxonase1 (PON1) in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Lack of association between paraoxonase-1 Q192R polymorphism and rheumatoid arthritis in southeast Iran.
Arthritis, Rheumatoid
Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease.
Arthritis, Rheumatoid
Paraoxonase and arylesterase levels in rheumatoid arthritis.
Arthritis, Rheumatoid
Serum esterase activity in reactive systemic amyloidosis and its relation to amyloid A degrading activity.
Arthritis, Rheumatoid
Serum paraoxonase activity decreases in rheumatoid arthritis.
Arthritis, Rheumatoid
The L55M polymorphism of paraoxonase-1 is a risk factor for rheumatoid arthritis.
arylesterase deficiency
Paraoxonase 1 deficiency and hyperhomocysteinemia alter the expression of mouse kidney proteins involved in renal disease.
arylesterase deficiency
Paraoxonase 1 deficiency in mice is associated with reduced steroid biosynthesis: Effects on HDL binding, cholesteryl ester accumulation and scavenger receptor type BI expression.
arylesterase deficiency
Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia.
arylesterase deficiency
Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease.
arylesterase deficiency
Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia.
arylesterase deficiency
Paraoxonase-1 Deficiency Is Associated with Severe Liver Steatosis in Mice Fed a High-fat High-cholesterol Diet: A Metabolomic Approach.
arylesterase deficiency
Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid.
Asthma
Association between the oxidative status, Vitamin D levels and respiratory function in asthmatic children.
Asthma
Evaluation of serum paraoxonase and arylesterase activities in subjects with asthma and chronic obstructive lung disease.
Asthma
Gene expression profiling of experimental asthma reveals a possible role of paraoxonase-1 in the disease.
Asthma
Influences of PON1 on airway inflammation and remodeling in bronchial asthma.
Asthma
Oxidative status and paraoxonase activity in children with asthma.
Asthma
Plasma paraoxonase activities, lipoprotein oxidation, and trace element interaction in asthmatic patients.
Asthma
Plasma paraoxonase, oxidative status level, and their relationship with asthma control test in children with asthma.
Asthma
Plasma protein thiols: an early marker of oxidative stress in asthma and chronic obstructive pulmonary disease.
Astrocytoma
Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.
Atherosclerosis
A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity.
Atherosclerosis
A multiplex PCR-based DNA assay for the detection of paraoxonase gene cluster polymorphisms.
Atherosclerosis
A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease.
Atherosclerosis
Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay.
Atherosclerosis
Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Atherosclerosis
Activity of paraoxonase 1 and lipid profile in healthy children.
Atherosclerosis
Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction.
Atherosclerosis
Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice.
Atherosclerosis
Alpha-tocopherol supplementation prevents the exercise-induced reduction of serum paraoxonase 1/arylesterase activities in healthy individuals.
Atherosclerosis
Alteration of PON1 Activity in Adult and Childhood Obesity and Its Relation to Adipokine Levels.
Atherosclerosis
Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice.
Atherosclerosis
Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype.
Atherosclerosis
Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population.
Atherosclerosis
Anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in Systemic Lupus Erythematosus.
Atherosclerosis
Anti-inflammatory properties of paraoxonase-1 in atherosclerosis.
Atherosclerosis
Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?
Atherosclerosis
Assessment of early atherosclerotic findings in patients with nasal polyposis.
Atherosclerosis
Assessment of paraoxonase activities in patients with knee osteoarthritis.
Atherosclerosis
Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Atherosclerosis
Assessment of Small C-Fiber Status for Screening of Oxidative Stress in Patients at Risk of Diabetes.
Atherosclerosis
Assessment of the role of paraoxonase gene polymorphism (Q192R) and paraoxonase activity in the susceptibility to atherosclerosis among lead-exposed workers.
Atherosclerosis
Association between PON1 rs662 polymorphism and coronary artery disease.
Atherosclerosis
Association between the paraoxonase-1 192Q>R allelic variant and coronary endothelial dysfunction in patients with early coronary artery disease.
Atherosclerosis
Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease.
Atherosclerosis
Association of lead, cadmium and mercury with paraoxonase 1 activity and malondialdehyde in a general population in Southern Brazil.
Atherosclerosis
Association of paraoxonase 55 and 192 gene polymorphisms on serum homocysteine concentrations in preeclampsia.
Atherosclerosis
Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.
Atherosclerosis
Association of paraoxonase activity and coronary blood flow.
Atherosclerosis
Association of paraoxonase activity and coronary collateral flow.
Atherosclerosis
Association of paraoxonase polymorphisms with carotid artery atherosclerosis in essential hypertension patients.
Atherosclerosis
Association of paraoxonase-1 L55M and Q192R polymorphisms with PCOS risk and potential risk factors for atherosclerosis.
Atherosclerosis
Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise.
Atherosclerosis
Atheroprotective mechanisms of HDL.
Atherosclerosis
Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities.
Atherosclerosis
Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage.
Atherosclerosis
Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.
Atherosclerosis
Betaine protects chronic alcohol and omega-3 PUFA-mediated down-regulations of PON1 gene, serum PON1 and homocysteine thiolactonase activities with restoration of liver GSH.
Atherosclerosis
Carotid intima-media thickness and paraoxonase activity in patients with ankylosing spondylitis.
Atherosclerosis
Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk.
Atherosclerosis
Concerning the Significance of Paraoxonase-1 and SR-B1 Genes in Atherosclerosis.
Atherosclerosis
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment.
Atherosclerosis
Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?
Atherosclerosis
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
Atherosclerosis
Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Atherosclerosis
Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.
Atherosclerosis
Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease.
Atherosclerosis
Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure.
Atherosclerosis
Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation.
Atherosclerosis
Effect of Eicosapentaenoic Acid Supplementation on Paraoxonase 2 Gene Expression in Patients with Type 2 Diabetes Mellitus: a Randomized Double-blind Clinical Trial.
Atherosclerosis
Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity.
Atherosclerosis
Effect of homocysteinylation on high density lipoprotein physico-chemical properties.
Atherosclerosis
Effect of levothyroxine replacement therapy on paraoxonase-1 and carotid intima-media thickness in subclinical hypothyroidism.
Atherosclerosis
Effect of Quercetin on Paraoxonase 2 Levels in RAW264.7 Macrophages and in Human Monocytes--Role of Quercetin Metabolism.
Atherosclerosis
Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats.
Atherosclerosis
Effects of cholesterol supplementation on antioxidant enzyme activities in rat hepatic tissues: possible implications of hepatic paraoxonase in atherogenesis.
Atherosclerosis
Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid.
Atherosclerosis
Efficacy of nobiletin in improving hypercholesterolemia and nonalcoholic fatty liver disease in high-cholesterol diet-fed mice.
Atherosclerosis
Endurance training reduces circulating asymmetric dimethylarginine and myeloperoxidase levels in persons at risk of coronary events.
Atherosclerosis
Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism.
Atherosclerosis
Evaluation of the future atherosclerotic heart disease with oxidative stress and carotid artery intima media thickness in gestational diabetes mellitus.
Atherosclerosis
Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein.
Atherosclerosis
Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation.
Atherosclerosis
Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice.
Atherosclerosis
Frequency of paraoxonase 192/55 polymorphism in an Iranian population.
Atherosclerosis
Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies.
Atherosclerosis
Functionally Defective High-Density Lipoprotein and Paraoxonase: A Couple for Endothelial Dysfunction in Atherosclerosis.
Atherosclerosis
Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity.
Atherosclerosis
Genetic polymorphisms and activity of PON1 in a Mexican population.
Atherosclerosis
Genetic polymorphisms of paraoxonase 1 and susceptibility to atherogenesis.
Atherosclerosis
Genetic variations of the paraoxonase gene in patients with coronary artery disease.
Atherosclerosis
Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.
Atherosclerosis
HDL capacity to inhibit LDL oxidation in well-trained triathletes.
Atherosclerosis
HDL--associated paraoxonase 1 (PON1) and dietary antioxidants attenuate lipoprotein oxidation, macrophage foam cells formation and atherosclerosis development.
Atherosclerosis
Hepatic paraoxonase 1 ameliorates dysfunctional high-density lipoprotein and atherosclerosis in scavenger receptor class B type I deficient mice.
Atherosclerosis
High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease.
Atherosclerosis
High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes.
Atherosclerosis
High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease.
Atherosclerosis
High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism.
Atherosclerosis
Higher frequency of paraoxonase gene polymorphism and cardiovascular impairment among Brazilian Fabry Disease patients.
Atherosclerosis
Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice.
Atherosclerosis
Human Paraoxonase Gene Cluster Transgenic Overexpression Represses Atherogenesis and Promotes Atherosclerotic Plaque Stability in ApoE-Null Mice.
Atherosclerosis
Human paraoxonase gene polymorphisms and coronary artery disease risk.
Atherosclerosis
Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.
Atherosclerosis
Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome.
Atherosclerosis
Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Atherosclerosis
Impact of paraoxonase polymorphism (Q192R) on endothelial function in intact coronary circulation.
Atherosclerosis
Impaired hepatic insulin signaling in PON2 deficient mice - a novel role for the PON2/ApoE axis on macrophage inflammatory response.
Atherosclerosis
Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis.
Atherosclerosis
Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease.
Atherosclerosis
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
Atherosclerosis
Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin.
Atherosclerosis
Infection and inflammation-induced proatherogenic changes of lipoproteins.
Atherosclerosis
Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease: a nutrigenetic observational study.
Atherosclerosis
Interaction of folate intake and the paraoxonase Q192R polymorphism with risk of incident coronary heart disease and ischemic stroke: the atherosclerosis risk in communities study.
Atherosclerosis
Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay.
Atherosclerosis
Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: comparison between humans and rats.
Atherosclerosis
Is elevated high-density lipoprotein cholesterol always good for coronary heart disease?
Atherosclerosis
Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis?
Atherosclerosis
Is paraoxonase related to atherosclerosis.
Atherosclerosis
Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypes.
Atherosclerosis
Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans.
Atherosclerosis
Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Atherosclerosis
Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study.
Atherosclerosis
Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
Atherosclerosis
Macrophage paraoxonase 2 regulates calcium homeostasis and cell survival under endoplasmic reticulum stress conditions and is sufficient to prevent the development of aggravated atherosclerosis in paraoxonase 2 deficiency/apoE(-/-) mice on a Western diet.
Atherosclerosis
Macrophages from alpha 7 nicotinic acetylcholine receptor knockout mice demonstrate increased cholesterol accumulation and decreased cellular paraoxonase expression: A possible link between the nervous system and atherosclerosis development.
Atherosclerosis
Mapping of microsatellite loci and association of aorta atherosclerosis with LG VI markers in the rabbit.
Atherosclerosis
Methionine sulfoxide reductase A attenuates atherosclerosis via repairing dysfunctional HDL in scavenger receptor class B type I deficient mice.
Atherosclerosis
Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Atherosclerosis
Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
Atherosclerosis
Modulation of paraoxonase 1 and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat.
Atherosclerosis
Molecular variant of the human paraoxonase/arylesterase gene is associated with central retinal vein occlusion in the Japanese population.
Atherosclerosis
Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex.
Atherosclerosis
Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity.
Atherosclerosis
No association of paraoxonase gene polymorphism with atherosclerosis or Alzheimer's disease.
Atherosclerosis
No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy.
Atherosclerosis
Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation.
Atherosclerosis
Normal lipid metabolism, familial hyperlipidaemia, lipid intervention and their benefits.
Atherosclerosis
Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.
Atherosclerosis
Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
Atherosclerosis
Oxidative status and serum PON1 activity in beta-thalassemia minor.
Atherosclerosis
Oxidative stress in vascular disease and its pharmacological prevention.
Atherosclerosis
Oxidative stress in white coat hypertension; role of paraoxonase.
Atherosclerosis
Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase.
Atherosclerosis
Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.
Atherosclerosis
Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis.
Atherosclerosis
Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.
Atherosclerosis
Paraoxonase 1 (PON1) and pomegranate influence circadian gene expression and period length.
Atherosclerosis
Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice.
Atherosclerosis
Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis.
Atherosclerosis
Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary event.
Atherosclerosis
Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery.
Atherosclerosis
Paraoxonase 1 and atherosclerosis-related diseases.
Atherosclerosis
Paraoxonase 1 and atherosclerosis: is the gene or the protein more important?
Atherosclerosis
Paraoxonase 1 and HDL maturation.
Atherosclerosis
Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients.
Atherosclerosis
Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries.
Atherosclerosis
Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk.
Atherosclerosis
Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis.
Atherosclerosis
Paraoxonase 1 Interactions with HDL, Antioxidants and Macrophages Regulate Atherogenesis - A Protective Role for HDL Phospholipids.
Atherosclerosis
Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins.
Atherosclerosis
Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease.
Atherosclerosis
Paraoxonase 1 polymorphism and prenatal pesticide exposure associated with adverse cardiovascular risk profiles at school age.
Atherosclerosis
Paraoxonase 1 polymorphisms as the risk factor of coronary heart disease in a Thai population.
Atherosclerosis
Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in healthy young men on a low-carotenoid diet supplemented with tomato juice.
Atherosclerosis
Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in R-allele-carrier but not in QQ homozygous elderly subjects on a tomato-rich diet.
Atherosclerosis
Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients.
Atherosclerosis
Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
Atherosclerosis
Paraoxonase 2 Deficiency Alters Mitochondrial Function and Exacerbates the Development of Atherosclerosis.
Atherosclerosis
Paraoxonase 2 Induces a Phenotypic Switch in Macrophage Polarization Favoring an M2 Anti-Inflammatory State.
Atherosclerosis
Paraoxonase activity in glomerulonephritic patients.
Atherosclerosis
Paraoxonase activity in human pericardial fluid: its relationship to coronary artery disease.
Atherosclerosis
Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia.
Atherosclerosis
Paraoxonase and arylesterase activities in fibromyalgia.
Atherosclerosis
Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major.
Atherosclerosis
Paraoxonase and atherosclerosis.
Atherosclerosis
Paraoxonase and other coronary risk factors in a community-based cohort.
Atherosclerosis
Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
Atherosclerosis
Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia.
Atherosclerosis
Paraoxonase gene polymorphisms and stroke severity.
Atherosclerosis
Paraoxonase genotype, LDL-oxidation and carotid atherosclerosis in male life-long smokers.
Atherosclerosis
Paraoxonase is reduced in patients with growth hormone deficiency: A novel risk factor for atherosclerosis.
Atherosclerosis
Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis.
Atherosclerosis
Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus.
Atherosclerosis
Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
Atherosclerosis
Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women.
Atherosclerosis
Paraoxonase-1 and adipokines: Potential links between obesity and atherosclerosis.
Atherosclerosis
Paraoxonase-1 and oxidative status in common Mediterranean {beta}-thalassaemia mutations trait, and their relations to atherosclerosis.
Atherosclerosis
Paraoxonase-1 and Symptomatic Status in Carotid Artery Disease.
Atherosclerosis
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications.
Atherosclerosis
Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia.
Atherosclerosis
Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients.
Atherosclerosis
Paraoxonase-1 gene Leu-Met55 and Gln-Arg192 polymorphisms are not associated with carotid artery atherosclerosis in a population-based cohort.
Atherosclerosis
Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus.
Atherosclerosis
Paraoxonase-1 is a better indicator than HDL of Atherosclerosis - A pilot study in North Indian population.
Atherosclerosis
Paraoxonase-1: Characteristics and role in atherosclerosis and carotid artery disease.
Atherosclerosis
Paraoxonase-2 Modulates Stress Response of Endothelial Cells to Oxidized Phospholipids and a Bacterial Quorum-Sensing Molecule.
Atherosclerosis
Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins.
Atherosclerosis
Plasma Paraoxonase-1, Oxidized Low-Density Lipoprotein and Lipid Peroxidation Levels in Gout Patients.
Atherosclerosis
Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles.
Atherosclerosis
Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases.
Atherosclerosis
PON gene polymorphisms and ischaemic stroke: a systematic review and meta analysis.
Atherosclerosis
PON1 and Mediterranean Diet.
Atherosclerosis
PON1 lactonase activity and its association with cardiovascular disease.
Atherosclerosis
PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
Atherosclerosis
PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients.
Atherosclerosis
Potential Association of Paraoxonase 1, Type 2 Diabetes Mellitus and Periodontitis.
Atherosclerosis
Protective effects of Xiongshao Capsule () on anti-inflammatory function of high-density lipoprotein in atherosclerosis rabbit model.
Atherosclerosis
Q192R polymorphism in the PON1 gene and familial hypercholesterolemia in a Saudi population.
Atherosclerosis
R192Q paraoxonase gene variant is associated with a change in HDL-cholesterol level during dietary caloric restriction in nondiabetic healthy males.
Atherosclerosis
Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?
Atherosclerosis
Reduced antioxidant capacity in children with iron deficiency and iron-deficiency anemia.
Atherosclerosis
Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.
Atherosclerosis
Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.
Atherosclerosis
Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat.
Atherosclerosis
Relationship between rs854560
Atherosclerosis
Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
Atherosclerosis
Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients.
Atherosclerosis
Relationship between the esterase paraoxonase-1 (PON1) and metal concentrations in the whole blood of Inuit in Canada.
Atherosclerosis
Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
Atherosclerosis
Relationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep South.
Atherosclerosis
Relationship of paraoxonase-1, malondialdehyde and mean platelet volume with markers of atherosclerosis in familial Mediterranean fever: an observational study.
Atherosclerosis
Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index.
Atherosclerosis
Renal cortical thickness and PON1 activity both decrease in chronic renal failure.
Atherosclerosis
Role of JNK and c-Jun signaling pathway in regulation of human serum paraoxonase-1 gene transcription by berberine in human HepG2 cells.
Atherosclerosis
Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients.
Atherosclerosis
Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.
Atherosclerosis
Serum cystatin C is a determinant of paraoxonase activity in hemodialyzed and renal transplanted patients.
Atherosclerosis
Serum Paraoxonase (PON1) Activity in North-West Indian Punjabi's with Acute Myocardial Infarction.
Atherosclerosis
Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome.
Atherosclerosis
Serum paraoxonase 1 activity in women with metabolic syndrome.
Atherosclerosis
Serum paraoxonase activities in hemodialyzed uremic patients: cohort study.
Atherosclerosis
Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
Atherosclerosis
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus.
Atherosclerosis
Serum paraoxonase activity is associated with epicardial fat tissue in renal transplant recipients.
Atherosclerosis
Serum paraoxonase activity is decreased in uremic patients.
Atherosclerosis
Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
Atherosclerosis
Serum Paraoxonase Levels are Correlated with Impaired Aortic Functions in Patients with Chronic Kidney Disease.
Atherosclerosis
Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Atherosclerosis
Serum paraoxonase-1 gene polymorphism and enzyme activity in patients with urolithiasis.
Atherosclerosis
Serum Paraoxonase-1 Levels are Significantly Decreased in the Presence of Insulin Resistance.
Atherosclerosis
Shift of the interconnection from the reaction system of paraoxonase 1 to the peroxidation reaction system of myeloperoxidase with HDL-C levels: a marker of atherosclerosis in patients with normal cholesterol levels.
Atherosclerosis
Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum.
Atherosclerosis
Some indazoles reduced the activity of human serum paraoxonase 1, an antioxidant enzyme: in vitro inhibition and molecular modeling studies.
Atherosclerosis
Sonographic evaluation of atherosclerosis burden in carotid arteries of ischemic stroke patients and its relation to paraoxonase 1 and 2, MTHFR and AT1R genetic variants.
Atherosclerosis
Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice.
Atherosclerosis
Study on molecular mechanisms of nattokinase in pharmacological action based on label-free liquid chromatography-tandem mass spectrometry.
Atherosclerosis
Synergism between apolipoprotein E ?4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
Atherosclerosis
Synergistic effect of polymorphisms of paraoxonase gene cluster and arsenic exposure on electrocardiogram abnormality.
Atherosclerosis
Targeting paraoxonase-1 in atherosclerosis.
Atherosclerosis
The associations between serum paraoxonase 1 activity and carotid atherosclerosis in renal transplant patients.
Atherosclerosis
The behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosis.
Atherosclerosis
The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.
Atherosclerosis
The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase.
Atherosclerosis
The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
Atherosclerosis
The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study.
Atherosclerosis
The growing importance of PON1 in cardiovascular health: a review.
Atherosclerosis
The Human Paraoxonase Gene Cluster as a Target in the Treatment of Atherosclerosis.
Atherosclerosis
The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters.
Atherosclerosis
The paraoxonase gene family and atherosclerosis.
Atherosclerosis
The paraoxonase gene family and coronary heart disease.
Atherosclerosis
The paraoxonase gene polymorphism in stroke patients and lipid profile.
Atherosclerosis
The relationship between lipoprotein-associated phospholipase A2 with cardiovascular risk factors in testosterone deficiency.
Atherosclerosis
The role of cholesterol-enriched diet and paraoxonase 1 inhibition in atherosclerosis progression.
Atherosclerosis
The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002).
Atherosclerosis
Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel.
Atherosclerosis
Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction.
Atherosclerosis
Treatment of atherosclerosis by transplantation of bone endothelial progenitor cells over-expressed paraoxonase-1 gene by recombinant adeno-associated virus in rat.
Atherosclerosis
Urokinase-type plasminogen activator downregulates paraoxonase 1 expression in hepatocytes by stimulating peroxisome proliferator-activated receptor-? nuclear export.
Atherosclerosis
Variation in paraoxonase-1 activity and atherosclerosis.
Atherosclerosis
[Biochemical studies on experimental atherosclerosis of the rabbit. Cholinesterases and arylesterase in the plasma and aortic wall. I. Technics and results in normal rabbits]
Atherosclerosis
[Biochemical studies on experimental atherosclerosis of the rabbit. Cholinesterases and arylesterase in the plasma and aortic wall. II. Results in a rabbit given an atherogenic diet]
Atherosclerosis
[Cholesterol oxidation, macrophage foam cells and atherosclerosis: importance of antioxidants and paraoxonase]
Atherosclerosis
[From organophosphate compound toxicity to atherosclerosis: role of paraoxonase 1]
Atherosclerosis
[The relation of serum paraoxonase-1 activity with isolated coronary artery ectasia: an observational study].
Autoimmune Diseases
Immunological manifestations in type I diabetic children.
Autoimmune Diseases
The Antioxidant Role of Paraoxonase 1 and Vitamin E in Three Autoimmune Diseases.
Babesiosis
Plasma biomarkers of SIRS and MODS associated with canine babesiosis.
Babesiosis
Relationship between paraoxonase 1 activity and high density lipoprotein concentration during naturally occurring babesiosis in dogs.
Bacteriuria
Erratum to: Preliminary study on serum paraoxonase-1 status and chemokine (C-C motif) ligand 2 in hospitalized elderly patients with catheter-associated asymptomatic bacteriuria.
Bacteriuria
Preliminary study on serum paraoxonase-1 status and chemokine (C-C motif) ligand 2 in hospitalized elderly patients with catheter-associated asymptomatic bacteriuria.
Behcet Syndrome
Paraoxonase and Arylesterase Levels in Behcet's Disease and Their Relations with the Disease Activity.
Behcet Syndrome
Purification of Paraoxonase Enzyme From the Sera of Patients with Behcet's Disease and Analyzing the Effects of the Drugs Containing Imuran (Azathioprine), Prednisolone (Methylprednisolone) and Colchium (Colchicine).
beta-Thalassemia
Oxidative status and serum PON1 activity in beta-thalassemia minor.
beta-Thalassemia
Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major.
beta-Thalassemia
Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients.
Blindness
Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration.
Bone Diseases, Metabolic
Paraoxonase-1 activity as a marker of atherosclerosis is not associated with low bone mineral density in healthy postmenopausal women.
Brain Neoplasms
Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1).
Breast Neoplasms
Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.
Breast Neoplasms
Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort.
Breast Neoplasms
Association of PON1, LEP and LEPR Polymorphisms with Susceptibility to Breast Cancer: A Meta-Analysis.
Breast Neoplasms
Association of Serum Paraoxonase 1 Activities, Polymorphisms and Oxidative Stress in Breast Cancer Patients with Type 2 Diabetes Mellitus.
Breast Neoplasms
Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients.
Breast Neoplasms
Genetic Polymorphisms of Paraoxonase 1 (PON1) Gene: Association Between L55M or Q192R with Breast Cancer Risk and Clinico-Pathological Parameters.
Breast Neoplasms
Liver X Receptor (LXR)-regulated Genes of Cholesterol Trafficking and Breast Cancer Severity.
Breast Neoplasms
Paired measurement of serum amyloid A (SAA) and paraoxonase 1 (PON1) as useful markers in breast cancer recurrence.
Breast Neoplasms
Paraoxonase 1 (PON1) as a marker of short term death in breast cancer recurrence.
Breast Neoplasms
Paraoxonase 1 gene polymorphisms are associated with an increased risk of breast cancer in a population of Chinese women.
Breast Neoplasms
Paraoxonase 1 genetic polymorphisms and susceptibility to breast cancer: A meta-analysis.
Breast Neoplasms
Polymorphisms in three obesity-related genes (LEP, LEPR, and PON1) and breast cancer risk: a meta-analysis.
Breast Neoplasms
Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer.
Bronchiectasis
Total oxidant and antioxidant status and paraoxonase 1 levels of children with noncystic fibrosis bronchiectasis
Calcinosis
Oxidative and antioxidant changes during formation of unstable atherosclerotic plaque.
Carcinoma
192R allele of paraoxanase 1 (PON1) gene as a new marker for susceptibility to bladder cancer.
Carcinoma
Acute phase proteins and biomarkers of oxidative status in feline spontaneous malignant mammary tumours.
Carcinoma
Arylesterase in serum: elaboration and clinical application of a fixed-incubation method.
Carcinoma
Assessment of PPARGC1A, PPARGC1B, and PON1 Genetic Polymorphisms in Esophageal Squamous Cell Carcinoma Susceptibility in the Eastern Chinese Han Population: A Case-Control Study Involving 2351 Subjects.
Carcinoma
Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma.
Carcinoma
Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.
Carcinoma
Serum paraoxonase-1 enzyme activities and oxidative stress levels in patients with esophageal squamous cell carcinoma.
Carcinoma, Hepatocellular
Amphenicol and Macrolide Derived Antibiotics Inhibit Paraoxonase Enzyme Activity in Human Serum and Human Hepatoma Cells (HepG2) in vitro.
Carcinoma, Hepatocellular
Arylesterase isoenzymes and activity in normal healthy adults and in patients with cancer and with other diseases.
Carcinoma, Hepatocellular
Differential effects of some antibiotics on paraoxonase enzyme activity on human hepatoma cells (HepG2) in vitro.
Carcinoma, Hepatocellular
Effect of lipoic acid on paraoxonase-1 and paraoxonase-3 protein levels, mRNA expression and arylesterase activity in liver hepatoma cells.
Carcinoma, Hepatocellular
Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival.
Carcinoma, Hepatocellular
Hypermethylation reduces the expression of PNPLA7 in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Lead inhibits paraoxonase 2 but not paraoxonase 1 activity in human hepatoma HepG2 cells.
Carcinoma, Hepatocellular
Quantitative Proteomic Analysis Identified Paraoxonase 1 as a Novel Serum Biomarker for Microvascular Invasion in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
Carcinoma, Non-Small-Cell Lung
Association of genetic polymorphisms in the paraoxonase 1 gene with the risk and prognosis of non-small cell lung cancer in chinese han population.
Carcinoma, Ovarian Epithelial
Genetic polymorphisms in the Paraoxonase 1 gene and risk of ovarian epithelial carcinoma.
Carcinoma, Ovarian Epithelial
Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
Carcinoma, Renal Cell
Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.
Cardiomegaly
Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice.
Cardiomyopathies
A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study.
Cardiomyopathies
FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice.
Cardiotoxicity
Propolis relieves the cardiotoxicity of chlorpyrifos in diabetic rats via alleviations of paraoxonase-1 and xanthine oxidase genes expression.
Cardiovascular Diseases
A half-marathon and a marathon run induce oxidative DNA damage, reduce antioxidant capacity to protect DNA against damage and modify immune function in hobby runners.
Cardiovascular Diseases
A meta-analysis on relationship between paraoxonase 1 polymorphisms and atherosclerotic cardiovascular diseases.
Cardiovascular Diseases
A new method for the determination of arylesterase activity in human serum using simulated body fluid.
Cardiovascular Diseases
A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women.
Cardiovascular Diseases
A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM.
Cardiovascular Diseases
Activity of Antioxidant Enzymes and Their Association with Lipid Profile in Mexican People without Cardiovascular Disease: An Analysis of Interactions.
Cardiovascular Diseases
Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease.
Cardiovascular Diseases
Alterations of HDL Particles in Children with End-stage Renal Disease.
Cardiovascular Diseases
An improved polymerase chain reaction-restriction fragment length polymorphism assay for the detection of a PON2 gene polymorphism.
Cardiovascular Diseases
Arylesterase activity and antioxidant status depend on PON1-Q192R and PON1-L55M polymorphisms in subjects with increased risk of cardiovascular disease consuming walnut-enriched meat.
Cardiovascular Diseases
Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet.
Cardiovascular Diseases
Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease.
Cardiovascular Diseases
Association of lead, cadmium and mercury with paraoxonase 1 activity and malondialdehyde in a general population in Southern Brazil.
Cardiovascular Diseases
Association of oxidative stress and paraoxonase status with PROCAM risk score.
Cardiovascular Diseases
Association of Paraoxonase 1 Polymorphism and Serum 25-Hydroxyvitamin D with the Risk of Cardiovascular Disease in Patients with Rheumatoid Arthritis.
Cardiovascular Diseases
Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits.
Cardiovascular Diseases
Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease.
Cardiovascular Diseases
Codon 311 (Cys --> Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias.
Cardiovascular Diseases
Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects.
Cardiovascular Diseases
Dietary Selenium (Se) and Vitamin E (V(E)) Supplementation Modulated Methylmercury-Mediated Changes in Markers of Cardiovascular Diseases in Rats.
Cardiovascular Diseases
Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis.
Cardiovascular Diseases
Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients.
Cardiovascular Diseases
Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol.
Cardiovascular Diseases
Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials.
Cardiovascular Diseases
Effects of Calcineurin Inhibitors on Paraoxonase and Arylesterase Activity After a Kidney Transplant.
Cardiovascular Diseases
Effects of Iron Supplementation With and Without Docosahexaenoic Acid on the Cardiovascular Disease Risk Based on Paraoxonase-1, hs-CRP, and ApoB/ApoA-I Ratio in Women with Iron Deficiency Anemia.
Cardiovascular Diseases
Effects of red wine consumption on serum paraoxonase/arylesterase activities and on lipoprotein oxidizability in healthy-men.
Cardiovascular Diseases
Effects of selenium supplementation on paraoxonase-1 and myeloperoxidase activity in subjects with cardiovascular disease: the Selenegene study, a double-blind randomized controlled trial.
Cardiovascular Diseases
Exogenous (Pomegranate Juice) or Endogenous (Paraoxonase1) Antioxidants Decrease Triacylglycerol Accumulation in Mouse Cardiovascular Disease-Related Tissues.
Cardiovascular Diseases
Factors Associated with Paraoxonase Genotypes and Activity in a Diverse, Young, Healthy Population: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Cardiovascular Diseases
Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism.
Cardiovascular Diseases
Genetic and environmental determinants of the PON-1 phenotype.
Cardiovascular Diseases
Genetic factors associated with the absence of atherosclerosis in octogenarians.
Cardiovascular Diseases
Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes.
Cardiovascular Diseases
HDL associated paraoxonase-1 activity correlates with systemic inflammation, disease activity and cardiovascular risk factors in psoriatic disease.
Cardiovascular Diseases
HDL-Associated Paraoxonase 1 as a Bridge between Postmenopausal Osteoporosis and Cardiovascular Disease.
Cardiovascular Diseases
HDL3-related decreased serum paraoxonase (PON) activity in uremic patients: comparison with the PON1 allele polymorphism.
Cardiovascular Diseases
Homocysteine threshold value based on cystathionine beta synthase and paraoxonase 1 activities in mice.
Cardiovascular Diseases
Hypertension in children (12-14 years)--a case-control study in Bursa, Turkey.
Cardiovascular Diseases
Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent - paraoxonase-1: The prospective cohort PREVEND study.
Cardiovascular Diseases
Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia.
Cardiovascular Diseases
Indices of paraoxonase and oxidative status do not enhance the prediction of subclinical cardiovascular disease in mixed-ancestry South Africans.
Cardiovascular Diseases
Induction of the paraoxonase-1 gene expression by resveratrol.
Cardiovascular Diseases
Influence of Human Paraoxonase-1 Polymorphism (Q192R) on Serum Levels of Clinical Biomarkers Indicatives of Cardiovascular Diseases Risk in Mexican Women.
Cardiovascular Diseases
Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease: a nutrigenetic observational study.
Cardiovascular Diseases
Interaction of folate intake and the paraoxonase Q192R polymorphism with risk of incident coronary heart disease and ischemic stroke: the atherosclerosis risk in communities study.
Cardiovascular Diseases
Low Serum Paraoxonase-1 Activity Associates with Incident Cardiovascular Disease Risk in Subjects with Concurrently High Levels of High-Density Lipoprotein Cholesterol and C-Reactive Protein.
Cardiovascular Diseases
Lower paraoxonase 1 activity in Tunisian bipolar I patients.
Cardiovascular Diseases
Methylmercury exposure, PON1 gene variants and serum paraoxonase activity in Eastern James Bay Cree adults.
Cardiovascular Diseases
Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
Cardiovascular Diseases
Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases.
Cardiovascular Diseases
No influence of increased intake of orange and blackcurrant juices and dietary amounts of vitamin E on paraoxonase-1 activity in patients with peripheral arterial disease.
Cardiovascular Diseases
No or only population-specific effect of PON1 on human longevity: A comprehensive meta-analysis.
Cardiovascular Diseases
Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina.
Cardiovascular Diseases
Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis.
Cardiovascular Diseases
Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.
Cardiovascular Diseases
Paraoxonase 1 (PON1) Q192R genotypes and their interaction with smoking strongly increase atherogenicity and the Framingham risk score.
Cardiovascular Diseases
Paraoxonase 1 activity as a predictor of cardiovascular disease in type 2 diabetes.
Cardiovascular Diseases
Paraoxonase 1 activity in subchronic low-level inorganic arsenic exposure through drinking water.
Cardiovascular Diseases
Paraoxonase 1 activity, concentration and genotype in cardiovascular disease.
Cardiovascular Diseases
Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients.
Cardiovascular Diseases
Paraoxonase 1 Gene L55M Polymorphism and Paraoxonase 1 Activity in Obstructive Sleep Apnea Patients.
Cardiovascular Diseases
Paraoxonase 1 gene polymorphisms and dementia in humans.
Cardiovascular Diseases
Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease.
Cardiovascular Diseases
Paraoxonase 192 polymorphism and its relationship to serum lipids in Turkish renal transplant recipients.
Cardiovascular Diseases
Paraoxonase activity in athletic adolescents.
Cardiovascular Diseases
Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
Cardiovascular Diseases
Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia.
Cardiovascular Diseases
Paraoxonase and arylesterase activities in coronary artery disease.
Cardiovascular Diseases
Paraoxonase and arylesterase activities in dipper and non-dipper prehypertensive subjects.
Cardiovascular Diseases
Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers.
Cardiovascular Diseases
Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
Cardiovascular Diseases
Paraoxonase and atherosclerosis-related cardiovascular diseases.
Cardiovascular Diseases
Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses.
Cardiovascular Diseases
Paraoxonase genotype and carotid intima-media thickness in children with familial hypercholesterolemia.
Cardiovascular Diseases
Paraoxonase levels in women with polycystic ovary syndrome.
Cardiovascular Diseases
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
Cardiovascular Diseases
Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients.
Cardiovascular Diseases
Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus.
Cardiovascular Diseases
Paraoxonase2 C311S polymorphism and low levels of HDL contribute to a higher mortality risk after acute myocardial infarction in elderly patients.
Cardiovascular Diseases
Paraoxonase: another factor in NIDDM cardiovascular disease.
Cardiovascular Diseases
Pharmacological interactions of paraoxonase 1 (PON1): A HDL-bound antiatherogenic enzyme.
Cardiovascular Diseases
Phenol-enriched olive oils modify paraoxonase-related variables: A randomized, crossover, controlled trial.
Cardiovascular Diseases
Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus.
Cardiovascular Diseases
PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death.
Cardiovascular Diseases
PONI and its association with oxidative stress in type I and type II diabetes mellitus.
Cardiovascular Diseases
Population differences in DNA sequence variation and linkage disequilibrium at the PON1 gene.
Cardiovascular Diseases
Preferential inhibition of paraoxonase activity of human paraoxonase 1 by negatively charged lipids.
Cardiovascular Diseases
Preservation of paraoxonase activity by wine flavonoids: possible role in protection of LDL from lipid peroxidation.
Cardiovascular Diseases
Review: The role of paraoxonase in cardiovascular diseases.
Cardiovascular Diseases
Salt overload in fructose-fed insulin-resistant rats decreases paraoxonase-1 activity.
Cardiovascular Diseases
Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
Cardiovascular Diseases
Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies.
Cardiovascular Diseases
Serum paraoxonase-1 activity is associated with light to moderate alcohol consumption: the PREVEND cohort study.
Cardiovascular Diseases
Serum paraoxonase-1 activity is inversely related to free thyroxine in euthyroid subjects: The PREVEND Cohort Study.
Cardiovascular Diseases
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1.
Cardiovascular Diseases
Solubilization and humanization of paraoxonase-1.
Cardiovascular Diseases
The epigenetic regulation of paraoxonase 1 (PON1) as an important enzyme in HDL function: The missing link between environmental and genetic regulation.
Cardiovascular Diseases
The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease.
Cardiovascular Diseases
The role of paraoxonase 1 activity in cardiovascular disease: potential for therapeutic intervention.
Carotid Artery Diseases
Evaluation of single nucleotide polymorphisms in 6 candidate genes and carotid intima-media thickness in community-dwelling residents.
Carotid Artery Diseases
Genetic factors associated with the absence of atherosclerosis in octogenarians.
Carotid Artery Diseases
Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.
Carotid Artery Diseases
Paraoxonase genotype, LDL-oxidation and carotid atherosclerosis in male life-long smokers.
Carotid Artery Diseases
Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.
Carotid Artery Diseases
Paraoxonase-1 and Symptomatic Status in Carotid Artery Disease.
Carotid Artery Diseases
Paraoxonase-1: Characteristics and role in atherosclerosis and carotid artery disease.
Carotid Artery Diseases
Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men.
Carotid Artery Diseases
The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer's patients.
Carotid Stenosis
Polymorphisms in the PON gene cluster are associated with Alzheimer disease.
Carotid Stenosis
The Association of Paraoxonase-1 Polymorphism with Carotid Artery Stenosis among Elderly Chinese Population.
Cataract
Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract.
Cataract
Expression and activity of paraoxonase 1 in human cataractous lens tissue.
Cataract
Paraoxonase-1 is associated with corneal endothelial cell alterations in patients with chronic obstructive pulmonary disease.
Cataract
Q192R paraoxonase1 polymorphism is a risk factor for cataract in Pakistani population.
Celiac Disease
Lipid peroxidation and paraoxonase-1 activity in celiac disease.
Celiac Disease
The Role of Oxidative Stress in the Etiopathogenesis of Gluten-sensitive Enteropathy Disease.
Cerebral Amyloid Angiopathy
No association of paraoxonase genotype or atherosclerosis with cerebral amyloid angiopathy.
Cerebral Hemorrhage
Association Between Paraoxonase Gene Polymorphisms and Intracerebral Hemorrhage in a Korean Population.
Cerebral Hemorrhage
Lack of association between the paraoxonase 1 Q/R192 single nucleotide polymorphism and stroke in a Chinese cohort.
Cerebral Infarction
Lack of association between the paraoxonase 1 Q/R192 single nucleotide polymorphism and stroke in a Chinese cohort.
Cerebral Infarction
Paraoxonase1 polymorphism Leu-Met55 is associated with cerebral infarction in Japanese population.
Cerebral Infarction
PON1 Hypermethylation and PON3 Hypomethylation are Associated with Risk of Cerebral Infarction.
Cerebral Infarction
Role of Paraoxonase 1 Activity and Oxidative/Antioxidative Stress Markers in Patients with Acute Cerebral Infarction.
Cerebrovascular Disorders
An improved polymerase chain reaction-restriction fragment length polymorphism assay for the detection of a PON2 gene polymorphism.
Cerebrovascular Disorders
Association between PON1 5'-regulatory region polymorphisms, PON1 activity and ischemic stroke.
Cerebrovascular Disorders
Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
Cerebrovascular Disorders
Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease.
Cerebrovascular Disorders
Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project.
Cholecystolithiasis
A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response.
Cholelithiasis
Evaluation of paraoxonase, malondialdehyde, and lipoprotein levels in patients with asymptomatic cholelithiasis.
Cholestasis, Intrahepatic
Placental ADAMTS-12 Levels in the Pathogenesis of Preeclampsia and Intrahepatic Cholestasis of Pregnancy.
Cholesteatoma
Oxidative stress in chronic otitis media.
Chorioamnionitis
Evaluation of Maternal Serum 25-Hydroxyvitamin D, Paraoxonase 1 Levels, and Neutrophil-to-Lymphocyte Ratio in Spontaneous Preterm Birth.
Choriocarcinoma
Adenocarcinoma of the colon with choriocarcinoma in its metastases.
Cleft Lip
Interactions between superoxide dismutase and paraoxonase polymorphic variants in nonsyndromic cleft lip with or without cleft palate in the Brazilian population.
Cleft Palate
Interactions between superoxide dismutase and paraoxonase polymorphic variants in nonsyndromic cleft lip with or without cleft palate in the Brazilian population.
Coinfection
Candida albicans increases the pathogenicity of Staphylococcus aureus during polymicrobial infection of Galleria mellonella larvae.
Colic
Menstruation distress is strongly associated with hormone-immune-metabolic biomarkers.
Colitis
Paraoxonase-1 suppresses experimental colitis via the inhibition of IFN-? production from CD4 T cells.
Colitis, Ischemic
Paraoxonase and arylesterase activities, lipid profile, and oxidative damage in experimental ischemic colitis model.
Colitis, Ulcerative
In vivo effects of curcumin on the paraoxonase, carbonic anhydrase, glucose-6-phosphate dehydrogenase and ?-glucosidase enzyme activities in dextran sulphate sodium-induced ulcerative colitis mice.
Colitis, Ulcerative
miR-155 targets Est-1 and induces ulcerative colitis via the IL-23/17/6-mediated Th17 pathway.
Colitis, Ulcerative
Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel disease.
Colitis, Ulcerative
Paraoxonase-1 and arylesterase levels in patients with ulcerative colitis.
Colitis, Ulcerative
Paraoxonase-1 status in Crohn's disease and ulcerative colitis.
Colitis, Ulcerative
Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis.
Colorectal Neoplasms
Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer.
Colorectal Neoplasms
Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human.
Colorectal Neoplasms
No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
Colorectal Neoplasms
Paraoxonase-1 and arylesterase activities in patients with colorectal cancer.
Colorectal Neoplasms
Serum lipid hydroperoxide levels and paraoxonase activity in patients with lung, breast, and colorectal cancer.
Communicable Diseases
Effect of continuous renal-replacement therapy on paraoxonase-1-related variables in patients with acute renal failure caused by septic shock.
Congenital Abnormalities
Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease.
Coronary Artery Disease
A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese.
Coronary Artery Disease
A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease.
Coronary Artery Disease
A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatin.
Coronary Artery Disease
A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease.
Coronary Artery Disease
Association between HDL particles size and myeloperoxidase/ paraoxonase-1 (MPO/PON1) ratio in patients with acute coronary syndrome.
Coronary Artery Disease
Association between paraoxonase 1 activity and severity of coronary artery disease in patients with acute coronary syndromes.
Coronary Artery Disease
Association between paraoxonase activity and lipid levels in patients with premature coronary artery disease.
Coronary Artery Disease
Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Coronary Artery Disease
Association between PON1 rs662 polymorphism and coronary artery disease.
Coronary Artery Disease
Association between the paraoxonase-1 192Q>R allelic variant and coronary endothelial dysfunction in patients with early coronary artery disease.
Coronary Artery Disease
Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
Coronary Artery Disease
Association of angiotensin-converting enzyme, methylene tetrahydrofolate reductase and paraoxonase gene polymorphism and coronary artery disease in an Indian population.
Coronary Artery Disease
Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
Coronary Artery Disease
Association of genetic variants in Methylenetetrahydrofolate Reductase and Paraoxonase-1 genes with homocysteine, folate and vitamin B12 in coronary artery disease.
Coronary Artery Disease
Association of lipids, lipoproteins, apolipoproteins and paraoxonase enzyme activity with premature coronary artery disease.
Coronary Artery Disease
Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease.
Coronary Artery Disease
Association of paraoxonase-1 M55L genotype and alcohol consumption with coronary atherosclerosis: the Helsinki Sudden Death Study.
Coronary Artery Disease
Association of paraoxonase1 gene Q192R polymorphism and apolipoprotein B in Asian Indian women with coronary artery disease risk.
Coronary Artery Disease
Associations between genetic polymorphisms of paraoxonase genes and coronary artery disease in a Taiwanese population.
Coronary Artery Disease
Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
Coronary Artery Disease
Cigarette smoking is associated with dose-dependent adverse effects on paraoxonase activity and fibrinogen in young women.
Coronary Artery Disease
Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk.
Coronary Artery Disease
Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients.
Coronary Artery Disease
Common paraoxonase gene variants, mortality risk and fatal cardiovascular events in elderly subjects.
Coronary Artery Disease
Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects.
Coronary Artery Disease
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment.
Coronary Artery Disease
Different pattern of association of paraoxonase Gln192-->Arg polymorphism with sporadic late-onset Alzheimer's disease and coronary artery disease.
Coronary Artery Disease
Diminished serum paraoxonase activity in patients with coronary artery calcification.
Coronary Artery Disease
Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery disease.
Coronary Artery Disease
Effects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for Patients Undergoing Percutaneous Coronary Intervention.
Coronary Artery Disease
Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke.
Coronary Artery Disease
Frequency distribution of the single-nucleotide -108C/T polymorphism at the promoter region of the PON1 gene in Asian Indians and its relationship with coronary artery disease.
Coronary Artery Disease
Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
Coronary Artery Disease
Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis.
Coronary Artery Disease
Genetic variations of the paraoxonase gene in patients with coronary artery disease.
Coronary Artery Disease
Genotypes of Common Polymorphisms in the PON1 Gene Associated with Paraoxonase Activity as Cardiovascular Risk Factor.
Coronary Artery Disease
Glycation impairs high-density lipoprotein function.
Coronary Artery Disease
High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease.
Coronary Artery Disease
Human paraoxonase gene cluster overexpression alleviates angiotensin II-induced cardiac hypertrophy in mice.
Coronary Artery Disease
Human paraoxonase gene polymorphisms and coronary artery disease risk.
Coronary Artery Disease
Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Coronary Artery Disease
Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality.
Coronary Artery Disease
Inhibitory effect of the paraoxonase gene on the formation of rabbit coronary atherosclerosis.
Coronary Artery Disease
Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
Coronary Artery Disease
Isolation and complete covalent structure of liver microsomal paraoxonase.
Coronary Artery Disease
Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Coronary Artery Disease
Low serum paraoxonase1 activity levels predict coronary artery disease severity.
Coronary Artery Disease
Low serum PON1 activity: An independent risk factor for coronary artery disease in North-West Indian type 2 diabetics.
Coronary Artery Disease
Mutations in the human paraoxonase 1 gene: frequencies, allelic linkages, and association with coronary artery disease.
Coronary Artery Disease
Oxidation and endothelial dysfunction biomarkers of atherosclerotic plaque instability. Studies of the vascular wall and blood.
Coronary Artery Disease
Oxidized-LDL and Paraoxonase-1 as biomarkers of Coronary Artery Disease in Patients with Sleep-Disordered Breathing.
Coronary Artery Disease
Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Coronary Artery Disease
Paraoxonase 1 gene (Q192R) polymorphism confers susceptibility to coronary artery disease in type 2 diabetes patients: Evidence from case-control studies.
Coronary Artery Disease
Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
Coronary Artery Disease
Paraoxonase 1 gene polymorphisms contribute to coronary artery disease risk among north Indians.
Coronary Artery Disease
Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians.
Coronary Artery Disease
Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis.
Coronary Artery Disease
Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
Coronary Artery Disease
Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease.
Coronary Artery Disease
Paraoxonase activity following exercise-based cardiac rehabilitation program.
Coronary Artery Disease
Paraoxonase activity in human pericardial fluid: its relationship to coronary artery disease.
Coronary Artery Disease
Paraoxonase and arylesterase activities in coronary artery disease.
Coronary Artery Disease
Paraoxonase and arylesterase activities in stent restenosis in bare metal stent.
Coronary Artery Disease
Paraoxonase Arg 192 allele is an independent risk factor for three-vessel stenosis of coronary artery disease.
Coronary Artery Disease
Paraoxonase gene polymorphism and coronary artery disease in Indian subjects.
Coronary Artery Disease
Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease.
Coronary Artery Disease
Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.
Coronary Artery Disease
Paraoxonase-1 (PON1) activity, but not PON1(Q192R) phenotype, is a predictor of coronary artery disease in a middle-aged Serbian population.
Coronary Artery Disease
Paraoxonase-1 activity and pleiotropic properties of simvastatin in obese and non-obese patients with stable coronary artery disease (CAD).
Coronary Artery Disease
Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease.
Coronary Artery Disease
Paraoxonase-1 Q192R polymorphism and its association with hs-CRP and fasting blood glucose levels and risk of coronary artery disease.
Coronary Artery Disease
Paraoxonase1, its Q192R polymorphism and HDL-cholesterol in relation to intensive cardiac care unit stay in ischemic heart disease.
Coronary Artery Disease
Polymorphisms in the PON gene cluster are associated with Alzheimer disease.
Coronary Artery Disease
PON gene polymorphisms and ischaemic stroke: a systematic review and meta analysis.
Coronary Artery Disease
PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery Disease.
Coronary Artery Disease
PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Coronary Artery Disease
Q192R polymorphism in the PON1 gene and familial hypercholesterolemia in a Saudi population.
Coronary Artery Disease
R/R genotype of human paraoxonase (PON1) is more protective against lipoprotein oxidation and coronary artery disease in Japanese subjects.
Coronary Artery Disease
Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.
Coronary Artery Disease
Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon 4 genes in early-onset coronary artery disease.
Coronary Artery Disease
Relationship between paraoxonase-1 (PON1) activity and lipoprotein (a) levels in Turkish coronary artery disease patients living in the Antalya region.
Coronary Artery Disease
Relationship between rs854560
Coronary Artery Disease
Relationship of microRNA 616 gene polymorphism with prognosis of patients with premature coronary artery disease.
Coronary Artery Disease
Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis.
Coronary Artery Disease
Smoking-dependent association between paraoxonase 1 M/L55 genotype and coronary atherosclerosis in males: an autopsy study.
Coronary Artery Disease
Strawberries Added to the Usual Diet Suppress Fasting Plasma Paraoxonase Activity and Have a Weak Transient Decreasing Effect on Cholesterol Levels in Healthy Nonobese Subjects.
Coronary Artery Disease
Synergism between paraoxonase Arg 192 and the angiotensin converting enzyme D allele is associated with severity of coronary artery disease.
Coronary Artery Disease
Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
Coronary Artery Disease
The association of paraoxonase 1 gene L55M polymorphism with the extent and severity of coronary artery disease in the Turkish population and its dependence on gender.
Coronary Artery Disease
The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role?
Coronary Artery Disease
The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.
Coronary Artery Disease
The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns.
Coronary Artery Disease
The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.
Coronary Artery Disease
The human paraoxonase Gln-Argl92 (Q/R) polymorphism in turkish patients with coronary artery disease.
Coronary Artery Disease
The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects.
Coronary Artery Disease
The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome.
Coronary Artery Disease
The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene.
Coronary Artery Disease
The role of paraoxonase (PON) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients.
Coronary Artery Disease
The Role of Paraoxonase 1 (PON1) Gene Polymorphisms in Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Coronary Artery Disease
Tobacco smoking, paraoxonase-1 (PON1) activity and pleiotropic effects of simvastatin treatment in patients with stable coronary artery disease (CAD).
Coronary Artery Disease
Two- and three-locus haplotypes of the paraoxonase (PON1) gene are associated with coronary artery disease in Asian Indians.
Coronary Artery Disease
[Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease]
Coronary Artery Disease
[Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease]
Coronary Artery Disease
[Smoking enhances the decrease of adiponectin level in patients with coronary artery disease, carriers of MTHFR 677T and PON1 55M alleles].
Coronary Artery Disease
[The relation of serum paraoxonase-1 activity with isolated coronary artery ectasia: an observational study].
Coronary Artery Disease
[The role of myeloperoxidase, paraoxonase and nitric oxide system in blood and pericardial fluid in patients with IHD who underwent direct myocardial revascularization.]
Coronary Disease
Allelic variants of the human scavenger receptor class B type 1 and paraoxonase 1 on coronary heart disease: genotype-phenotype correlations.
Coronary Disease
An alternative pseudolikelihood method for multivariate random-effects meta-analysis.
Coronary Disease
Association Between Paraoxonase 2 Ser311Cys Polymorphism and Coronary Heart Disease Risk: A Meta-Analysis.
Coronary Disease
Associations of HDL phospholipids and paraoxonase activity with coronary heart disease in postmenopausal women.
Coronary Disease
Associations of the PON1 rs662 polymorphism with circulating oxidized low-density lipoprotein and lipid levels: a systematic review and meta-analysis.
Coronary Disease
Autopsy and postmortem examination case study on genetic risk factors for cardiac death: polymorphisms of endothelial nitric oxide synthase gene Glu298Asp variant and T-786C mutation, human paraoxonase 1 (PON1) gene and alpha2beta-adrenergic receptor gene.
Coronary Disease
Characterization of paraoxonase activity in pericardial fluid: usefulness as a marker of coronary disease.
Coronary Disease
Codon 311 (Cys --> Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias.
Coronary Disease
Diabetes mellitus and the late complications: influence of the genetic factors.
Coronary Disease
Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxonase gene.
Coronary Disease
Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
Coronary Disease
DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease.
Coronary Disease
Do PON1-Q192R and PON1-L55M polymorphisms modify the effects of hypoxic training on paraoxonase and arylesterase activity?
Coronary Disease
Does paraoxonase play a role in susceptibility to cardiovascular disease?
Coronary Disease
Effect of statin therapy on plasma high-density lipoprotein-cholesterol levels is modified by paraoxonase 1 in Chinese patients with coronary heart disease.
Coronary Disease
Four genetic polymorphisms of paraoxonase gene and risk of coronary heart disease: a meta-analysis based on 88 case-control studies.
Coronary Disease
Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studies.
Coronary Disease
Gene:environment interaction in lipid metabolism and effect on coronary heart disease risk.
Coronary Disease
Genetic polymorphism of paraoxonase and the risk of coronary heart disease.
Coronary Disease
Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity.
Coronary Disease
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.
Coronary Disease
High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease.
Coronary Disease
High-density lipoprotein cholesterol and paraoxonase 1 (PON1) genetics and serum PON1 activity in prepubertal children in Spain.
Coronary Disease
Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study.
Coronary Disease
Human paraoxonase gene cluster polymorphisms as predictors of coronary heart disease risk in the prospective Northwick Park Heart Study II.
Coronary Disease
Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study.
Coronary Disease
Interaction effects between Paraoxonase 1 variants and cigarette smoking on risk of coronary heart disease in a Singaporean Chinese population.
Coronary Disease
Interaction of folate intake and the paraoxonase Q192R polymorphism with risk of incident coronary heart disease and ischemic stroke: the atherosclerosis risk in communities study.
Coronary Disease
LL-paraoxonase genotype is associated with a more severe degree of homeostasis model assessment IR in healthy subjects.
Coronary Disease
Mercury, eicosapentanoic acid and docosahexaenoic acid demonstrate limited effect on plasma paraoxonase-1 activity and blood pressure among avid seafood consumers in the Long Island Study of Seafood Consumption, NY, USA.
Coronary Disease
Molecular characterization and expression analysis of the porcine paraoxonase 3 (PON3) gene.
Coronary Disease
New chemiluminescent substrates of paraoxonase 1 with improved specificity: synthesis and properties.
Coronary Disease
Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.
Coronary Disease
Paraoxonase 1 (Q192R) gene polymorphism, coronary heart disease and the risk of a new acute coronary event.
Coronary Disease
Paraoxonase 1 activity, concentration and genotype in cardiovascular disease.
Coronary Disease
Paraoxonase 1 Activity, Lipid Profile, and Atherogenic Indexes Status in Coronary Heart Disease.
Coronary Disease
Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery.
Coronary Disease
Paraoxonase 1 Polymorphisms and Risk of Myocardial Infarction in Women and Men.
Coronary Disease
Paraoxonase 1 polymorphisms and survival.
Coronary Disease
Paraoxonase 1 polymorphisms as the risk factor of coronary heart disease in a Thai population.
Coronary Disease
Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study.
Coronary Disease
Paraoxonase activity in two healthy populations with differing rates of coronary heart disease.
Coronary Disease
Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies.
Coronary Disease
Paraoxonase and coronary heart disease risk: language misleads, linkage misinforms, function clarifies.
Coronary Disease
Paraoxonase and coronary heart disease.
Coronary Disease
Paraoxonase and other coronary risk factors in a community-based cohort.
Coronary Disease
Paraoxonase gene cluster variations associated with coronary heart disease in Chinese Han women.
Coronary Disease
Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
Coronary Disease
Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease.
Coronary Disease
Paraoxonase gene Q192R & L55M polymorphisms in Indians with acute myocardial infarction & association with oxidized low density lipoprotein.
Coronary Disease
Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease.
Coronary Disease
Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus.
Coronary Disease
Paraoxonase polymorphisms and coronary heart disease.
Coronary Disease
Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.
Coronary Disease
Paraoxonase promoter polymorphism T(-107)C and relative paraoxonase deficiency as determinants of risk of coronary artery disease.
Coronary Disease
Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?
Coronary Disease
Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease.
Coronary Disease
Paraoxonase-1 L55M polymorphism is associated with an abnormal oral glucose tolerance test and differentiates high risk coronary disease families.
Coronary Disease
Paraoxonase-1 promoter polymorphism C--107T and serum apolipoprotein AI interact to modulate serum paraoxonase-1 status.
Coronary Disease
Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins.
Coronary Disease
Polymorphisms of pon1 and pon2 genes in hemodialyzed patients.
Coronary Disease
PON2 and PPARG polymorphisms as biomarkers of risk for coronary heart disease.
Coronary Disease
Positive Clinical Response to Clopidogrel is Independent of Paraoxonase 1 Q192R and CYP2C19 Genetic Variants.
Coronary Disease
Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients.
Coronary Disease
Quantitative Assessment of the Influence of Paraoxonase 1 Activity and Coronary Heart Disease Risk.
Coronary Disease
Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
Coronary Disease
Role of angiotensin converting enzyme, paraoxonase 1 55, 192 gene polymorphisms in syndrome X and coronary heart disease.
Coronary Disease
Serum apolipoprotein j in health, coronary heart disease and type 2 diabetes mellitus.
Coronary Disease
Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins.
Coronary Disease
Significant association between paraoxonase 1 rs662 polymorphism and coronary heart disease : A meta-analysis in the Chinese population.
Coronary Disease
Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease.
Coronary Disease
The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese.
Coronary Disease
The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.
Coronary Disease
The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease.
Coronary Disease
The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study.
Coronary Disease
The impact of cytochrome 450 and Paraoxonase polymorphisms on clopidogrel resistance and major adverse cardiac events in coronary heart disease patients after percutaneous coronary intervention.
Coronary Disease
The paraoxonase gene family and coronary heart disease.
Coronary Disease
The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease.
Coronary Disease
The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose.
Coronary Disease
Unexpectedly higher diazoxon hydrolysis by serum paraoxonase-1 in coronary heart disease.
Coronary Disease
[Age related decrease of high density lipoproteins (HDL) in women after menopause. Quantification of HDL with genetically determined HDL arylesterase in women with healthy coronary vessels and in women with angiographically verified coronary heart disease]
Coronary Disease
[Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease]
Coronary Disease
[Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease]
Coronary Disease
[Paraoxonase, something more than an enzyme?]
Coronary Disease
[Relationships between PON1 L55M polymorphism and coronary heart diseases complicated with fasting hyperglycemia in Han populations in Guangdong]
Coronary Disease
[Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease]
Coronary Disease
[The paraoxonase Gln-Arg192 polymorphism in patients with coronary heart disease in Chinese population]
Coronary Stenosis
Matrix metalloproteinase-9 and paraoxonase 1 Q/R192 gene polymorphisms and the risk of coronary artery stenosis in Iranian subjects.
Coronary Stenosis
Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease.
COVID-19
Altered high-density lipoprotein composition and functions during severe COVID-19.
Crohn Disease
Correlation of Paraoxonase-1 with the Severity of Crohn's Disease.
Crohn Disease
P074. Circulating adipokynes and Paraoxonase-1 activity in overweight Crohn's disease patients.
Crohn Disease
Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel disease.
Crohn Disease
Paraoxonase-1 status in Crohn's disease and ulcerative colitis.
Cushing Syndrome
CONDITIONING FACTORS FOR HIGH CARDIOVASCULAR RISK IN PATIENTS WITH CUSHING SYNDROME.
cystathionine beta-synthase deficiency
Lipid, Oxidative and Inflammatory Profile and Alterations in the Enzymes Paraoxonase and Butyrylcholinesterase in Plasma of Patients with Homocystinuria Due CBS Deficiency: The Vitamin B12 and Folic Acid Importance.
cystathionine beta-synthase deficiency
Paraoxonase-1 expression is up-regulated in Down syndrome fetal liver.
Cystic Fibrosis
An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism.
Cystic Fibrosis
Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase.
Cystic Fibrosis
Expression of PPAR? and Paraoxonase 2 Correlated with Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Cystic Fibrosis
Identification and analysis of the salt tolerant property of AHL lactonase (AiiATSAWB ) of Bacillus species.
Cystic Fibrosis
Linkage between the loci for cystic fibrosis and paraoxonase.
Cystic Fibrosis
Linkage relationships of paraoxonase (PON) with other markers: indication of PON-cystic fibrosis synteny.
Cystic Fibrosis
Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes.
Cystic Fibrosis
Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis.
Cystic Fibrosis
The Sweat Metabolome of Screen-Positive Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.
Cystitis
Evaluation of oxidative stress status and antioxidant capacity in patients with painful bladder syndrome/interstitial cystitis: preliminary results of a randomised study.
Cysts
Esterase activity in the guinea pig thyroid under normal and pathological conditions (vitamin A deficiency) with special regard to cyst-like structures.
Dementia
Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.
Dementia
Catalytic properties and distribution profiles of paraoxonase and cholinesterase phenotypes in human sera.
Dementia
Codon 311 (Cys --> Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias.
Dementia
Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia.
Dementia
Paraoxonase 1 (PON1) gene -108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia.
Dementia
Paraoxonase 1 decline and lipid peroxidation rise reflect a degree of brain atrophy and vascular impairment in dementia.
Dementia
Paraoxonase 1 gene polymorphisms and dementia in humans.
Dementia
Paraoxonase activity and dementia.
Dementia
PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia.
Dementia
Positive correlation of paraoxonase 1 (PON1) activity with serum insulin level and HOMA-IR in dementia. A possible advantageous role of PON1 in dementia development.
Dementia
Profile of the Paraoxonase 1 (PON1) Gene 192Q/R Polymorphism and Clinical Associations among Older Singaporean Chinese with Alzheimer's and Mixed Dementia.
Dementia
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study.
Dementia
The relationship between serum paraoxonase levels and carotid atherosclerotic plaque formation in Alzheimer's patients.
Dementia
[The early diagnosis and differential diagnosis of Alzheimer's disease with clinical methods]
Dementia, Vascular
Arylesterase Activity of Paraoxonase-1 in Serum and Cerebrospinal Fluid of Patients with Alzheimer's Disease and Vascular Dementia.
Dementia, Vascular
Assessment of Paraoxonase 1 Activity in Patients With Alzheimer's Disease and Vascular Dementia.
Dementia, Vascular
Association of adiponectin, leptin and resistin with inflammatory markers and obesity in dementia.
Dementia, Vascular
Codon 311 (Cys --> Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias.
Dementia, Vascular
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
Dementia, Vascular
Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia.
Dementia, Vascular
Paraoxonase 1 decline and lipid peroxidation rise reflect a degree of brain atrophy and vascular impairment in dementia.
Dementia, Vascular
Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
Dementia, Vascular
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study.
Dementia, Vascular
Synergistic Epistasis of Paraoxonase 1 (rs662 and rs85460) and Apolipoprotein E4 Genes in Pathogenesis of Alzheimer's Disease and Vascular Dementia.
Diabetes Complications
Association between PON 1 polymorphisms, PON activity and diabetes complications.
Diabetes Complications
Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes.
Diabetes Complications
Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.
Diabetes Complications
PON1 55 and 192 Gene Polymorphisms in Type 2 Diabetes Mellitus Patients in a Turkish Population.
Diabetes Mellitus
Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.
Diabetes Mellitus
Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects.
Diabetes Mellitus
Association between paraoxonase 1 activity and severity of coronary artery disease in patients with acute coronary syndromes.
Diabetes Mellitus
Association of cholesteryl ester transfer protein genotypes with paraoxonase-1 activity, lipid profile and oxidative stress in type 2 diabetes mellitus: A study in San Luis, Argentina.
Diabetes Mellitus
Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
Diabetes Mellitus
Association of PON2 Gene Polymorphisms (Ser311Cys and Ala148Gly) With the Risk of Developing Type 2 Diabetes Mellitus in the Chinese Population.
Diabetes Mellitus
Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
Diabetes Mellitus
Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes.
Diabetes Mellitus
Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease.
Diabetes Mellitus
Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control.
Diabetes Mellitus
Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.
Diabetes Mellitus
Cross-sectional correlates of paraoxonase 1 and soluble intercellular adhesion molecule-1 in metabolic syndrome patients with and without diabetes.
Diabetes Mellitus
Decrease of serum paraoxonase activity in chronic renal failure.
Diabetes Mellitus
Effect of Eicosapentaenoic Acid Supplementation on Paraoxonase 2 Gene Expression in Patients with Type 2 Diabetes Mellitus: a Randomized Double-blind Clinical Trial.
Diabetes Mellitus
Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Diabetes Mellitus
Effect of Lipoic Acid on Serum Paraoxonase-1 and Paraoxonase-3 Protein Levels and Activities in Diabetic Rats.
Diabetes Mellitus
Effects of n-3 Polyunsaturated Fatty Acids (PUFAs) on Circulating Adiponectin and Leptin in Subjects with Type 2 Diabetes Mellitus.
Diabetes Mellitus
Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus.
Diabetes Mellitus
Effects of vitamin A, C and E, or omega-3 fatty acid supplementation on the level of paraoxonase and arylesterase activity in streptozotocin-induced diabetic rats: an investigation of activities in plasma, and heart and liver homogenates.
Diabetes Mellitus
Ethnic variations in paraoxonase1 polymorphism in the Malaysian population.
Diabetes Mellitus
European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus.
Diabetes Mellitus
Evaluation of Relationship Between Arylesterase-Based Activity and Genetic Variants of Paraoxonase1 in T2DM Patients within Golestan Province.
Diabetes Mellitus
Gender differences in the association of gene polymorphisms with type 2 diabetes mellitus.
Diabetes Mellitus
Genetic risk for restenosis after coronary balloon angioplasty.
Diabetes Mellitus
Gln-Arg192 polymorphism of paraoxonase 1 is associated with carotid intima-media thickness in patients of type 2 diabetes mellitus of Chinese.
Diabetes Mellitus
Glycation impairs high-density lipoprotein function.
Diabetes Mellitus
HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
Diabetes Mellitus
Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay.
Diabetes Mellitus
Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus.
Diabetes Mellitus
Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Diabetes Mellitus
Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.
Diabetes Mellitus
Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance.
Diabetes Mellitus
Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in turkish patients with type 2 diabetes mellitus.
Diabetes Mellitus
Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Diabetes Mellitus
Paraoxonase 1 activities and its gene promoter single nucleotide polymorphisms (-108, -126, and -162) in diabetes mellitus.
Diabetes Mellitus
Paraoxonase 1 activity as a predictor of cardiovascular disease in type 2 diabetes.
Diabetes Mellitus
Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery.
Diabetes Mellitus
Paraoxonase 1 gene (Q192R) polymorphism confers susceptibility to coronary artery disease in type 2 diabetes patients: Evidence from case-control studies.
Diabetes Mellitus
Paraoxonase 1 gene polymorphisms and enzyme activities in diabetes mellitus.
Diabetes Mellitus
Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus.
Diabetes Mellitus
Paraoxonase 1: a better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus.
Diabetes Mellitus
Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
Diabetes Mellitus
Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporal lipid precipitation.
Diabetes Mellitus
Paraoxonase lactonase activity, inflammation and antioxidant status in plasma of patients with type 1 diabetes mellitus.
Diabetes Mellitus
Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus.
Diabetes Mellitus
Paraoxonase-1 activities in children and adolescents with type 1 diabetes mellitus.
Diabetes Mellitus
Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.
Diabetes Mellitus
Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus.
Diabetes Mellitus
Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.
Diabetes Mellitus
Pharmacological interactions of paraoxonase 1 (PON1): A HDL-bound antiatherogenic enzyme.
Diabetes Mellitus
Potential Association of Paraoxonase 1, Type 2 Diabetes Mellitus and Periodontitis.
Diabetes Mellitus
Prevalence of paraoxonase-1 polymorphisms in diabetes mellitus type 2 Greek patients.
Diabetes Mellitus
Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.
Diabetes Mellitus
Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
Diabetes Mellitus
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.
Diabetes Mellitus
Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications.
Diabetes Mellitus
Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.
Diabetes Mellitus
Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Diabetes Mellitus
Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects.
Diabetes Mellitus
Study on paraoxonase 1 in type 2 diabetes mellitus.
Diabetes Mellitus
The association between paraoxonase 1 activity and the susceptibilities of diabetes mellitus, diabetic macroangiopathy and diabetic microangiopathy.
Diabetes Mellitus
The Effect of Eicosapentaenoic Acid on the Serum Levels and Enzymatic Activity of Paraoxonase 1 in the Patients With Type 2 Diabetes Mellitus.
Diabetes Mellitus
The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis.
Diabetes Mellitus
The relationship of oral disturbances of diabetes mellitus patients with paraoxonase gene polymorphisms.
Diabetes Mellitus
Vitamin E Improves Serum Paraoxonase-1 Activity and Some Metabolic Factors in Patients with Type 2 Diabetes: No Effects on Nitrite/Nitrate Levels.
Diabetes Mellitus
[A search for association between the polymorphic markers of PON1 and PON2 genes and diabetic nephropathy in patients with type I diabetes mellitus]
Diabetes Mellitus
[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal]
Diabetes Mellitus
[Relationships between PON1 L55M polymorphism and coronary heart diseases complicated with fasting hyperglycemia in Han populations in Guangdong]
Diabetes Mellitus
[Study of SOD and PON-1 expression in type 2 diabetes mellitus nephropathy and its clinical significance].
Diabetes Mellitus
[The association of paraoxonase 2 gene C311S variant with ischemic stroke in Chinese type 2 diabetes mellitus patients]
Diabetes Mellitus
[The effects of paraoxonase-1 and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus]
Diabetes Mellitus, Type 1
A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM.
Diabetes Mellitus, Type 1
Association between p.Leu54Met polymorphism at the paraoxonase-1 gene and plantar fascia thickness in young subjects with type 1 diabetes.
Diabetes Mellitus, Type 1
Association between PON 1 polymorphisms, PON activity and diabetes complications.
Diabetes Mellitus, Type 1
Can paraoxonase 1 polymorphisms (L55 M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?
Diabetes Mellitus, Type 1
Evaluation of paraoxonase 1 arylesterase activity and lipid peroxide levels in patients with type 1 diabetes.
Diabetes Mellitus, Type 1
High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes.
Diabetes Mellitus, Type 1
Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.
Diabetes Mellitus, Type 1
Paraoxonase gene cluster is a genetic marker for early microvascular complications in type 1 diabetes.
Diabetes Mellitus, Type 1
Paraoxonase lactonase activity, inflammation and antioxidant status in plasma of patients with type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
Paraoxonase-1 activities in children and adolescents with type 1 diabetes mellitus.
Diabetes Mellitus, Type 1
Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls.
Diabetes Mellitus, Type 1
Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.
Diabetes Mellitus, Type 1
[A search for association between the polymorphic markers of PON1 and PON2 genes and diabetic nephropathy in patients with type I diabetes mellitus]
Diabetes Mellitus, Type 2
Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
Diabetes Mellitus, Type 2
Arylesterase activity but not PCSK9 levels is associated with chronic kidney disease in type 2 diabetes.
Diabetes Mellitus, Type 2
Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies.
Diabetes Mellitus, Type 2
Association between M/L55-polymorphism of paraoxonase enzyme and oxidative DNA damage in patients with type 2 diabetes mellitus and in control subjects.
Diabetes Mellitus, Type 2
Association between promoter polymorphism (-108C>T) of paraoxonase1 gene and it(')s paraoxonase activity in patients with Type2 diabetes in northern Iran.
Diabetes Mellitus, Type 2
Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Association of PON2 Gene Polymorphisms (Ser311Cys and Ala148Gly) With the Risk of Developing Type 2 Diabetes Mellitus in the Chinese Population.
Diabetes Mellitus, Type 2
Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
Diabetes Mellitus, Type 2
Association of Serum Paraoxonase 1 Activities, Polymorphisms and Oxidative Stress in Breast Cancer Patients with Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes.
Diabetes Mellitus, Type 2
Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control.
Diabetes Mellitus, Type 2
Correlation between the activities of lipoprotein lipase and paraoxonase in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Cross-sectional correlates of paraoxonase 1 and soluble intercellular adhesion molecule-1 in metabolic syndrome patients with and without diabetes.
Diabetes Mellitus, Type 2
Decreased paraoxonase 2 enzymatic activity in monocyte/macrophages cells. A comparative in vivo and in vitro study for diabetes.
Diabetes Mellitus, Type 2
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.
Diabetes Mellitus, Type 2
Effect of Eicosapentaenoic Acid Supplementation on Paraoxonase 2 Gene Expression in Patients with Type 2 Diabetes Mellitus: a Randomized Double-blind Clinical Trial.
Diabetes Mellitus, Type 2
Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Diabetes Mellitus, Type 2
Effect of pomegranate juice on paraoxonase enzyme activity in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Effects of n-3 Polyunsaturated Fatty Acids (PUFAs) on Circulating Adiponectin and Leptin in Subjects with Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
Effects of rosiglitazone on serum paraoxonase activity and metabolic parameters in patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Gender differences in the association of gene polymorphisms with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes.
Diabetes Mellitus, Type 2
Gln-Arg192 polymorphism of paraoxonase 1 is associated with carotid intima-media thickness in patients of type 2 diabetes mellitus of Chinese.
Diabetes Mellitus, Type 2
Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes.
Diabetes Mellitus, Type 2
HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
Diabetes Mellitus, Type 2
Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
Diabetes Mellitus, Type 2
Importance of paraoxonase 1 (PON1) as an antioxidant and antiatherogenic enzyme in the cardiovascular complications of type 2 diabetes: Genotypic and phenotypic evaluation.
Diabetes Mellitus, Type 2
Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent - paraoxonase-1: The prospective cohort PREVEND study.
Diabetes Mellitus, Type 2
Investigation of the relationship between atherosclerosis and paraoxonase or homocysteine thiolactonase activity in patients with type 2 diabetes mellitus using a commercially available assay.
Diabetes Mellitus, Type 2
Leisure time physical activity is associated with improved HDL functionality in high cardiovascular risk individuals: a cohort study.
Diabetes Mellitus, Type 2
Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Lower Serum Paraoxonase-1 Activity Is Related to Linoleic and Docosahexanoic Fatty Acids in Patients with Type 2 Diabetes.
Diabetes Mellitus, Type 2
Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients.
Diabetes Mellitus, Type 2
Paraoxonase (PON1) 55 and 192 polymorphism and its effects to oxidant-antioxidant system in turkish patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Paraoxonase 1 (PON1)-L55M among common variants in the coding region of the paraoxonase gene family may contribute to the glycemic control in type 2 diabetes.
Diabetes Mellitus, Type 2
Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
Diabetes Mellitus, Type 2
Paraoxonase 1 activity as a predictor of cardiovascular disease in type 2 diabetes.
Diabetes Mellitus, Type 2
Paraoxonase 1 Activity in Chylomicrons and VLDL: The Effect of Type 2 Diabetes and Meals Rich in Saturated Fat and Oleic Acid.
Diabetes Mellitus, Type 2
Paraoxonase 1 gene (Q192R) polymorphism confers susceptibility to coronary artery disease in type 2 diabetes patients: Evidence from case-control studies.
Diabetes Mellitus, Type 2
Paraoxonase 1 gene polymorphisms concerning non-insulin-dependent diabetes mellitus nephropathy in hemodialysis patients.
Diabetes Mellitus, Type 2
Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Paraoxonase 1 phenotype distribution and activity differs in subjects with newly diagnosed Type 2 diabetes (the CODAM Study).
Diabetes Mellitus, Type 2
Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
Diabetes Mellitus, Type 2
Paraoxonase 1: a better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76.
Diabetes Mellitus, Type 2
Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Paraoxonase, oxidized low density lipoprotein, monocyte chemoattractant protein-1 and adhesion molecules are associated with macrovascular complications in patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles.
Diabetes Mellitus, Type 2
Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Paraoxonase-1 is not associated with coronary artery calcification in type 2 diabetes: Results from the PREDICT study.
Diabetes Mellitus, Type 2
Paraoxonase: another factor in NIDDM cardiovascular disease.
Diabetes Mellitus, Type 2
Plasma markers of endothelial dysfunction in type 2 diabetics.
Diabetes Mellitus, Type 2
Potential Association of Paraoxonase 1, Type 2 Diabetes Mellitus and Periodontitis.
Diabetes Mellitus, Type 2
Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Relationship of High-Density Lipoprotein-Associated Arylesterase Activity to Systolic Heart Failure in Patients with and without Type 2 Diabetes.
Diabetes Mellitus, Type 2
Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications.
Diabetes Mellitus, Type 2
Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.
Diabetes Mellitus, Type 2
Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Diabetes Mellitus, Type 2
Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects.
Diabetes Mellitus, Type 2
Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes.
Diabetes Mellitus, Type 2
Study on paraoxonase 1 in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation.
Diabetes Mellitus, Type 2
The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.
Diabetes Mellitus, Type 2
The Effect of Eicosapentaenoic Acid on the Serum Levels and Enzymatic Activity of Paraoxonase 1 in the Patients With Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
The effect of meals rich in thermally stressed olive and safflower oils on postprandial serum paraoxonase activity in patients with diabetes.
Diabetes Mellitus, Type 2
The effect of resveratrol supplementation on serum levels of asymmetric de-methyl-arginine and paraoxonase 1 activity in patients with type 2 diabetes: A randomized, double-blind controlled trial.
Diabetes Mellitus, Type 2
The gene-treatment interaction of paraoxonase-1 gene polymorphism and statin therapy on insulin secretion in Japanese patients with type 2 diabetes: Fukuoka diabetes registry.
Diabetes Mellitus, Type 2
The Met54Leu polymorphism of paraoxonase (PON) enzyme gene is not a genetic risk factor for non-insulin-dependent diabetes mellitus in Finns.
Diabetes Mellitus, Type 2
The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis.
Diabetes Mellitus, Type 2
The Q192R polymorphism of the paraoxonase-1 (PON1) gene is associated with susceptibility to gestational diabetes mellitus in the Greek population.
Diabetes Mellitus, Type 2
The Ser311Cys variation in the paraoxonase 2 gene increases the risk of type 2 diabetes in northern Chinese.
Diabetes Mellitus, Type 2
Vitamin E Improves Serum Paraoxonase-1 Activity and Some Metabolic Factors in Patients with Type 2 Diabetes: No Effects on Nitrite/Nitrate Levels.
Diabetes Mellitus, Type 2
[Genetic polymorphism of pyruvate dehydrogenase kinase 4 (PDK4), paraoxonase 2 (PON2), and fatty acid binding protein 2 (FABP2) in the NIDDM population of Senegal]
Diabetes Mellitus, Type 2
[Relationships between PON1 L55M polymorphism and coronary heart diseases complicated with fasting hyperglycemia in Han populations in Guangdong]
Diabetes Mellitus, Type 2
[Study of SOD and PON-1 expression in type 2 diabetes mellitus nephropathy and its clinical significance].
Diabetes Mellitus, Type 2
[The association of paraoxonase 2 gene C311S variant with ischemic stroke in Chinese type 2 diabetes mellitus patients]
Diabetes, Gestational
Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
Diabetes, Gestational
Evaluation of the future atherosclerotic heart disease with oxidative stress and carotid artery intima media thickness in gestational diabetes mellitus.
Diabetes, Gestational
Lactonase activity and status of paraoxonase 1 and oxidative stress in neonates of women with gestational diabetes mellitus.
Diabetes, Gestational
Lactonase Activity, Status, and Genetic Variations of Paraoxonase 1 in Women with Gestational Diabetes Mellitus.
Diabetes, Gestational
Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity.
Diabetes, Gestational
Relationship between the paraoxonase 1 gene glutamine 192 to arginine polymorphism and gestational diabetes mellitus in Saudi women.
Diabetes, Gestational
The Q192R polymorphism of the paraoxonase-1 (PON1) gene is associated with susceptibility to gestational diabetes mellitus in the Greek population.
Diabetic Angiopathies
The association between paraoxonase 1 activity and the susceptibilities of diabetes mellitus, diabetic macroangiopathy and diabetic microangiopathy.
Diabetic Angiopathies
The Associations between Paraoxonase 1 L55M/Q192R Genetic Polymorphisms and the Susceptibilities of Diabetic Macroangiopathy and Diabetic Microangiopathy: A Meta-Analysis.
Diabetic Foot
Diet and paraoxonase 1 enzymatic activity in diabetic foot patients from romania and belgium: favorable association of high flavonoid dietary intake with arylesterase activity.
Diabetic Foot
Investigation of ischemia-modified albumin levels and some atherosclerosis-related serum parameters in patients with diabetic foot.
Diabetic Nephropathies
Association of paraoxonase gene polymorphisms with diabetic nephropathy and retinopathy.
Diabetic Nephropathies
Comment--to: Pinizzotto M, Castillo E, Fiaux M, Temler E, Gaillard RC, Ruiz J (2001) Paraoxonase 2 polymorphisms are associated with diabetic nephropathy in Type II diabetes. Diabetologia 44: 104-107.
Diabetic Nephropathies
Evaluation of Paraoxonase, Arylesterase, and Homocysteine Thiolactonase Activities in Patients with Diabetes and Incipient Diabetes Nephropathy.
Diabetic Nephropathies
Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy.
Diabetic Nephropathies
Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.
Diabetic Nephropathies
Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes.
Diabetic Nephropathies
Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus.
Diabetic Nephropathies
Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
Diabetic Nephropathies
Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.
Diabetic Nephropathies
[A search for association between the polymorphic markers of PON1 and PON2 genes and diabetic nephropathy in patients with type I diabetes mellitus]
Diabetic Nephropathies
[The effects of paraoxonase-1 and oxidized low density lipoprotein on nephropathy in type-2 diabetes mellitus]
Diabetic Retinopathy
A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM.
Diabetic Retinopathy
Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.
Diabetic Retinopathy
Association of paraoxonase gene polymorphisms with diabetic nephropathy and retinopathy.
Diabetic Retinopathy
Homocysteinethiolactone and paraoxonase: novel markers of diabetic retinopathy.
Disorders of Excessive Somnolence
Sleepiness, inflammation and oxidative stress markers in middle-aged males with obstructive sleep apnea without metabolic syndrome: a cross-sectional study.
Down Syndrome
Paraoxonase-1 expression is up-regulated in Down syndrome fetal liver.
Drug Resistant Epilepsy
An evaluation of serum paraoxonase together with arylesterase activities and oxidative stress in children with intractable epilepsy: a cross-sectional study.
Dyslipidemias
Accelerated atherosclerosis in rheumatoid arthritis.
Dyslipidemias
Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease.
Dyslipidemias
Association of midgestation paraoxonase 1 activity and pregnancies complicated by preterm birth.
Dyslipidemias
Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats.
Dyslipidemias
Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial.
Dyslipidemias
Hypertension in children (12-14 years)--a case-control study in Bursa, Turkey.
Dyslipidemias
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Dyslipidemias
Molecular characterization and expression analysis of the porcine paraoxonase 3 (PON3) gene.
Dyslipidemias
Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients.
Dyslipidemias
Q192R Polymorphism of Paraoxonase 1 Gene Associated with Insulin Resistance in Mexican Children.
Dyslipidemias
Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Dyslipidemias
The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia.
Dyslipidemias
[Fish by-products oil corrects dyslipidemia, improves reverse cholesterol transport and stimulates paraoxonase-1 activity in obese rat].
Echinococcosis
Oxidant/Antioxidant Status, PON1 and ARES Activities, Trace Element Levels, and Histological Alterations in Sheep with Cystic Echinococcosis.
Endometrial Neoplasms
Assessment of serum paraoxonase and arylesterase activity in patients with endometrial cancer.
Endometrial Neoplasms
Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer.
Endometriosis
Association between Serum Paraoxonase 1 Activities (PONase/AREase) and L55M Polymorphism in Risk of Female Infertility.
Endometriosis
Atherosclerotic cardiovascular disease in women with endometriosis: a systematic review of risk factors and prospects for early surveillance.
Endometriosis
Serum paraoxonase-1 activity in women with endometriosis and its relationship with the stage of the disease.
Endometriosis
Serum tumor necrosis factor-?, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility.
Endometriosis
There is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study.
Endotoxemia
Serial measurements of Paraoxonase-1 (PON-1) activity in horses with experimentally induced endotoxemia.
Endotoxemia
Serum butyrylcholinesterase and paraoxonase 1 in a canine model of endotoxemia: Effects of choline administration.
Enteritis
Inflammatory and oxidative biomarkers of disease severity in dogs with parvoviral enteritis.
Epilepsy
Changes in the anti-oxidant system in adult epilepsy patients receiving anti-epileptic drugs.
Erectile Dysfunction
Assessment of the acute effects of tadalafil on the cardiovascular system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: a preliminary study.
Erectile Dysfunction
Paraoxonase activity in patients with erectile dysfunction.
Esophageal Neoplasms
Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer.
Esophageal Squamous Cell Carcinoma
Assessment of PPARGC1A, PPARGC1B, and PON1 Genetic Polymorphisms in Esophageal Squamous Cell Carcinoma Susceptibility in the Eastern Chinese Han Population: A Case-Control Study Involving 2351 Subjects.
Esophageal Squamous Cell Carcinoma
Serum paraoxonase-1 enzyme activities and oxidative stress levels in patients with esophageal squamous cell carcinoma.
Essential Hypertension
Association of paraoxonase 1 (PON1) gene polymorphisms and concentration with essential hypertension.
Essential Hypertension
Association of paraoxonase polymorphisms with carotid artery atherosclerosis in essential hypertension patients.
Essential Hypertension
Q192R Paraoxonase (PON)1 Polymorphism, Insulin Sensitivity, and Endothelial Function in Essential Hypertensive Men.
Essential Tremor
Paraoxonase 1 (PON1) polymorphisms and risk for essential tremor.
Exfoliation Syndrome
Evaluation of oxidative stress and paraoxonase phenotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
Exfoliation Syndrome
Paraoxonase 1 (PON1) promoter (-107T/C) and coding region (192Q/R and 55L/M) genetic variations in pseudoexfoliation syndrome and pseudoexfoliative glaucoma risk.
Exfoliation Syndrome
The Activities of Paraoxonase, Xanthine Oxidase, Adenosine Deaminase and the Level of Nitrite in Pseudoexfoliation Syndrome.
Exfoliation Syndrome
Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma.
Fabry Disease
Higher frequency of paraoxonase gene polymorphism and cardiovascular impairment among Brazilian Fabry Disease patients.
Fabry Disease
Paraoxonase (PON1) Gene Polymorphisms in Fabry Disease: Correlation with Renal Disease.
Familial Mediterranean Fever
Cu/Zn-superoxide dismutase, paraoxonase and arylesterase activities and malondialdehyde levels in patients with familial mediterranean fever.
Familial Mediterranean Fever
Genetic polymorphisms of paraoxonase1 192 and glutathione peroxidase1 197 enzymes in familial Mediterranean fever.
Familial Mediterranean Fever
Paraoxonase 1 and arylesterase levels in children with familial mediterranean fever.
Familial Mediterranean Fever
Relationship of paraoxonase-1, malondialdehyde and mean platelet volume with markers of atherosclerosis in familial Mediterranean fever: an observational study.
Fatty Liver
A new marker for lipid peroxidation: Serum paraoxonase activity in non-alcoholic steatohepatitis.
Fatty Liver
A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease.
Fatty Liver
Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease.
Fatty Liver
Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors.
Fatty Liver
Cytokines, paraoxonase-1, periostin and non-invasive liver fibrosis scores in patients with non-alcoholic fatty liver disease and persistently elevated aminotransferases: A pilot study.
Fatty Liver
Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.
Fatty Liver
Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis.
Fatty Liver
Paraoxonase activity in sera of patients with non-alcoholic fatty liver disease.
Fatty Liver
Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Fatty Liver
Paraoxonase-1 Deficiency Is Associated with Severe Liver Steatosis in Mice Fed a High-fat High-cholesterol Diet: A Metabolomic Approach.
Fatty Liver
Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease.
Fatty Liver
Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.
Fatty Liver
Serum Paraoxonase as an Indicator for Fatty Liver in Sheep.
Fatty Liver
Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows.
Feline Infectious Peritonitis
Role of paraoxonase-1 as a diagnostic marker for feline infectious peritonitis.
Feline Infectious Peritonitis
Serum biomarkers of oxidative stress in cats with feline infectious peritonitis.
Fibromyalgia
Paraoxonase and arylesterase activities in fibromyalgia.
Fibrosarcoma
Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis.
Gaucher Disease
Severe systemic immune response syndrome, low plasma paraoxonase activity, and a new albumin species in a traumatized patient with Gaucher's disease.
Glaucoma
Decreased paraoxonase1 activity and increased malondialdehyde and oxidative DNA damage levels in primary open angle glaucoma.
Glaucoma
Evaluation of oxidative stress and paraoxonase phenotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.
Glaucoma
Higher serum lipids and oxidative stress in patients with normal tension glaucoma, but not pseudoexfoliative glaucoma.
Glaucoma
Paraoxonase 1 (PON1) promoter (-107T/C) and coding region (192Q/R and 55L/M) genetic variations in pseudoexfoliation syndrome and pseudoexfoliative glaucoma risk.
Glaucoma
Total oxidative stress, paraoxonase and arylesterase levels at patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma.
Glaucoma, Open-Angle
Decreased paraoxonase1 activity and increased malondialdehyde and oxidative DNA damage levels in primary open angle glaucoma.
Glaucoma, Open-Angle
Paraoxonase 1 gene polymorphisms influence clinical features of open-angle glaucoma.
Glioblastoma
Valproic acid inhibits glioblastoma multiforme cell growth via paraoxonase 2 expression.
Glioma
Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas.
Glioma
The Paraoxonase 1 Gene c.-108C>T SNP in the Promoter Is Associated with Risk for Glioma in Mexican Patients, but Not the p.L55M or p.Q192R Polymorphisms in the Coding Region.
Glomerulonephritis
Paraoxonase 1 polymorphisms in patients with primary glomerulonephritis: a single-center study in Turkey.
Glomerulonephritis
Paraoxonase activity in glomerulonephritic patients.
Glomerulonephritis, IGA
Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy.
Glomerulonephritis, Membranoproliferative
Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children?
Glomerulosclerosis, Focal Segmental
Genetic polymorphism in paraoxonase is a risk factor for childhood focal segmental glomerulosclerosis.
Glucose Intolerance
Adaptive response of rat pancreatic ?-cells to insulin resistance induced by monocrotophos: Biochemical evidence.
Glucose Intolerance
Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance.
Glucose Intolerance
Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Genetic polymorphisms in paraoxonase 1 and G protein-coupled receptor 77, and the risk of glucose-6-phosphate dehydrogenase deficiency in a Saudi population.
Glucosephosphate Dehydrogenase Deficiency
Genetic polymorphisms in paraoxonase 1 and G protein-coupled receptor 77, and the risk of glucose-6-phosphate dehydrogenase deficiency in a Saudi population.
Gout
Plasma Paraoxonase-1, Oxidized Low-Density Lipoprotein and Lipid Peroxidation Levels in Gout Patients.
Head and Neck Neoplasms
Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy.
Hearing Loss, Noise-Induced
Association between Paraoxonase 2 Gene Polymorphisms and Noise-induced Hearing Loss in the Chinese Population.
Hearing Loss, Noise-Induced
Paraoxonase 3 gene polymorphisms are associated with occupational noise-induced deafness: A matched case-control study from China.
Hearing Loss, Noise-Induced
Paraoxonase and superoxide dismutase gene polymorphisms and noise-induced hearing loss.
Hearing Loss, Sensorineural
Prognostic value of serum anti-heat-shock protein 70 and paraoxonase levels in idiopathic sudden sensorineural hearing loss.
Hearing Loss, Sensorineural
The relationship between thiol-disulfide balance and idiopathic sudden sensorineural hearing loss.
Heart Diseases
Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
Heart Diseases
Effects of paraoxonase 1 gene polymorphisms on heart diseases: Systematic review and meta-analysis of 64 case-control studies.
Heart Diseases
HDL associated paraoxonase-1 activity correlates with systemic inflammation, disease activity and cardiovascular risk factors in psoriatic disease.
Heart Diseases
Immunobiochemical analysis of Paraoxonase1 (anti-oxidant), xanthine oxidase (oxidant) enzymes and lipid profile of cardiac disease patients in Lahore Metropolitan, Pakistan.
Heart Diseases
Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and beta-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes--an 8-year prospective cohort analysis of 1297 patients.
Heart Diseases
Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.
Heart Diseases
Phenotype distribution of the paraoxonase gene in patients with cardiac disease.
Heart Diseases
The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease.
Heart Diseases
[Age related decrease of high density lipoproteins (HDL) in women after menopause. Quantification of HDL with genetically determined HDL arylesterase in women with healthy coronary vessels and in women with angiographically verified coronary heart disease]
Heart Failure
High-density lipoprotein-associated paraoxonase-1 activity for prediction of adverse outcomes in outpatients with chronic heart failure.
Heart Failure
Paraoxonase 2 prevents the development of heart failure.
Heart Failure
[Congestive heart failure and paraoxonase]
Heart Failure, Systolic
Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure.
Heart Failure, Systolic
Relationship of High-Density Lipoprotein-Associated Arylesterase Activity to Systolic Heart Failure in Patients with and without Type 2 Diabetes.
Hemangioma, Cavernous, Central Nervous System
GLYOXALASE I A111E, PARAOXONASE 1 Q192R AND L55M POLYMORPHISMS IN ITALIAN PATIENTS WITH SPORADIC CEREBRAL CAVERNOUS MALFORMATIONS: A PILOT STUDY.
Hemochromatosis
Paraoxonase-1 status in patients with hereditary hemochromatosis.
Hemorrhagic Fever, Crimean
Effects of Paraoxonase-1 variants on course of severity and mortality of Crimean-Congo hemorrhagic fever.
Hemorrhagic Stroke
Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.
Hepatitis
Paraoxonase-1 activity is related to Trichinella spiralis-induced hepatitis in rats.
Hepatitis
[Enteric sorbents potentiate hepatoprotective effect of eplir in experimental toxic hepatitis]
Hepatitis
[Oxidative stress and semen parameters in the serum and seminal plasma of infertile men with chronic viral hepatitis].
Hepatitis
[Serum arylesterase activity in patients with acute viral hepatitis]
Hepatitis B
Association of Paraoxonase 1 Gene Polymorphisms With the Risk of Hepatitis B Virus-related Liver Diseases in a Guangxi Population: A Case-control Study.
Hepatitis B
Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B.
Hepatitis B
Serum paraoxonase and arylesterase activities in various forms of hepatitis B virus infection.
Hepatitis B, Chronic
Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.
Hepatitis B, Chronic
Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities.
Hepatitis C
Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus.
Hepatitis C
Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
Hepatitis C
PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Hepatitis C, Chronic
Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection.
Hepatitis C, Chronic
[Investigation of the association between paraoxonase-1 gene polymorphisms and response to therapy in chronic hepatitis C patients].
Hepatitis, Alcoholic
Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B.
Hepatitis, Chronic
Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection.
Hepatitis, Chronic
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases.
Hepatitis, Chronic
Serum arylesterase and paraoxonase activity in patients with chronic hepatitis.
Hepatitis, Chronic
Serum arylesterase isoenzymes in chronic hepatitis.
Hepatitis, Chronic
Serum Basal Paraoxonase 1 Activity as an Additional Liver Function Test for the Evaluation of Patients with Chronic Hepatitis.
Hepatitis, Chronic
Serum paraoxonase and arylesterase activities for the evaluation of patients with chronic hepatitis.
Hepatitis, Chronic
[Proceedings: Correlation between histological data and arylesterase isoenzyme behavior in chronic hepatitis]
Hepatomegaly
[Serum cholinesterase and arylesterase in cirrhosis and steatosic hepatomegaly]
Hepatopulmonary Syndrome
Nitric oxide metabolites, nitrative stress, and paraoxonase activity in hepatopulmonary syndrome.
HIV Infections
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection.
Homocystinuria
Lipid, Oxidative and Inflammatory Profile and Alterations in the Enzymes Paraoxonase and Butyrylcholinesterase in Plasma of Patients with Homocystinuria Due CBS Deficiency: The Vitamin B12 and Folic Acid Importance.
Homocystinuria
Paraoxonase-1 expression is up-regulated in Down syndrome fetal liver.
Hydatidiform Mole
No association between serum paraoxonase, arylesterase activities, and hydatidiform mole.
Hyperandrogenism
Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.
Hyperandrogenism
The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome.
Hypercholesterolemia
Anthocyanin supplementation improves HDL-associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia.
Hypercholesterolemia
Atherosclerotic cardiovascular disease in women with endometriosis: a systematic review of risk factors and prospects for early surveillance.
Hypercholesterolemia
Bovine lactoferrin ameliorates antioxidant esterase activity and 8-isoprostane levels in high-cholesterol-diet fed rats.
Hypercholesterolemia
Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy.
Hypercholesterolemia
Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance.
Hypercholesterolemia
Genetic risk for restenosis after coronary balloon angioplasty.
Hypercholesterolemia
Oxysterols Increase Inflammation, Lipid Marker Levels and Reflect Accelerated Endothelial Dysfunction in Experimental Animals.
Hyperemesis Gravidarum
Paraoxonase-1 activity in patients with hyperemesis gravidarum.
Hyperemesis Gravidarum
Serum lipid profile, oxidative status, and paraoxonase 1 activity in hyperemesis gravidarum.
Hyperglycemia
An aqueous extract of Murraya koenigii leaves induces paraoxonase 1 activity in streptozotocin induced diabetic mice.
Hyperglycemia
Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Hyperglycemia
Glabridin, an isoflavan from licorice root, upregulates paraoxonase 2 expression under hyperglycemia and protects it from oxidation.
Hyperglycemia
Serum oxidized low density lipoprotein, paraoxonase 1 and lipid peroxidation levels during oral glucose tolerance test.
Hyperglycemia
The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation.
Hyperglycemia
[Fish by-products oil corrects dyslipidemia, improves reverse cholesterol transport and stimulates paraoxonase-1 activity in obese rat].
Hyperglycemia
[Relationships between PON1 L55M polymorphism and coronary heart diseases complicated with fasting hyperglycemia in Han populations in Guangdong]
Hyperhomocysteinemia
Altered gene expression in liver from a murine model of hyperhomocysteinemia.
Hyperhomocysteinemia
Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise.
Hyperhomocysteinemia
Corrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia.
Hyperhomocysteinemia
Effect of red wine polyphenol dietary supplementation on two phase II enzymes in liver of hyperhomocysteinemic mice.
Hyperhomocysteinemia
Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance.
Hyperhomocysteinemia
Effects of catechin on homocysteine metabolism in hyperhomocysteinemic mice.
Hyperhomocysteinemia
Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice.
Hyperhomocysteinemia
Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Hyperhomocysteinemia
Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease.
Hyperhomocysteinemia
Mouse liver paraoxonase-1 gene expression is downregulated in hyperhomocysteinemia.
Hyperhomocysteinemia
Paraoxonase 1 and dietary hyperhomocysteinemia modulate the expression of mouse proteins involved in liver homeostasis.
Hyperhomocysteinemia
Paraoxonase 1 deficiency and hyperhomocysteinemia alter the expression of mouse kidney proteins involved in renal disease.
Hyperhomocysteinemia
Paraoxonase-1 activity determination via paraoxon substrate yields no significant difference in mild hyperhomocysteinemia.
Hyperhomocysteinemia
Paraoxonase-1 expression is up-regulated in Down syndrome fetal liver.
Hyperhomocysteinemia
Role of Genetic Background in Cardiovascular Risk Markers Changes in Water Polo Players.
Hyperinsulinism
Adaptive response of rat pancreatic ?-cells to insulin resistance induced by monocrotophos: Biochemical evidence.
Hyperinsulinism
Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Hyperlipidemia, Familial Combined
An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia.
Hyperlipidemia, Familial Combined
Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.
Hyperlipidemia, Familial Combined
Paraoxonase (PON1) is associated with familial combined hyperlipidemia.
Hyperlipidemias
An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia.
Hyperlipidemias
Associations between HDL oxidation and paraoxonase-1 and paraoxonase-1 gene polymorphisms in families affected by familial combined hyperlipidemia.
Hyperlipidemias
Can Carob-Fruit-Extract-Enriched Meat Improve the Lipoprotein Profile, VLDL-Oxidation, and LDL Receptor Levels Induced by an Atherogenic Diet in STZ-NAD-Diabetic Rats?
Hyperlipidemias
Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient.
Hyperlipidemias
Hyperlipidemia-induced hepatic and small intestine ER stress and decreased paraoxonase 1 expression and activity is associated with HDL dysfunction in Syrian hamsters.
Hyperlipidemias
Paraoxonase (PON1) is associated with familial combined hyperlipidemia.
Hyperlipidemias
Paraoxonase and arylesterase activities in stent restenosis in bare metal stent.
Hyperlipidemias
Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia.
Hyperlipidemias
Single intravenous injection of plasmid DNA encoding human paraoxonase-1 inhibits hyperlipidemia in rats.
Hyperlipidemias
The effect of fenofibrate on serum paraoxonase activity and inflammatory markers in patients with combined hyperlipidemia.
Hyperlipidemias
The effect of red grape seed extract on serum paraoxonase activity in patients with mild to moderate hyperlipidemia.
Hyperlipoproteinemia Type II
Decrease of serum paraoxonase activity in chronic renal failure.
Hyperlipoproteinemia Type II
Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene.
Hyperlipoproteinemia Type II
Erratum: Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene.
Hyperlipoproteinemia Type II
Indications that paraoxonase-1 contributes to plasma high density lipoprotein levels in familial hypercholesterolemia.
Hyperlipoproteinemia Type II
Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia.
Hyperlipoproteinemia Type II
Paraoxonase genotype and carotid intima-media thickness in children with familial hypercholesterolemia.
Hyperlipoproteinemia Type II
Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia.
Hyperlipoproteinemia Type II
Variation at the paraoxonase gene locus contributes to carotid arterial wall thickness in subjects with familial hypercholesterolemia.
Hyperlipoproteinemias
Changes in paraoxonase and apolipoprotein A-I, B, C-III and E in subjects with combined familiar hyperlipoproteinemia treated with ciprofibrate.
Hypertension
Atherosclerotic cardiovascular disease in women with endometriosis: a systematic review of risk factors and prospects for early surveillance.
Hypertension
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.
Hypertension
Effect of valsartan, an angiotensin II receptor blocker, on markers of oxidation and glycation in Japanese type 2 diabetic subjects: blood pressure-independent effect of valsartan.
Hypertension
Genetic background in apolipoprotein A-I and cystathionine beta-synthase deficiency.
Hypertension
Genetic risk for restenosis after coronary balloon angioplasty.
Hypertension
HDL associated paraoxonase-1 activity correlates with systemic inflammation, disease activity and cardiovascular risk factors in psoriatic disease.
Hypertension
Hypertension in children (12-14 years)--a case-control study in Bursa, Turkey.
Hypertension
Identification of differential gene expression profile from peripheral blood cells of military pilots with hypertension by RNA sequencing analysis.
Hypertension
Oxidative stress in white coat hypertension; role of paraoxonase.
Hypertension
Paraoxonase (PON1) 55 Polymorphism and Association with Systemic Lupus Erythematosus.
Hypertension
Paraoxonase and arylesterase activities in dipper and non-dipper prehypertensive subjects.
Hypertension
Paraoxonase and arylesterase activities in stent restenosis in bare metal stent.
Hypertension
Roles of Paraoxonase and Oxidative Stress in Adolescents with Uraemic, Essential or Obesity-Induced Hypertension.
Hypertension
The inverse association of HDL-cholesterol with future risk of hypertension is not modified by its antioxidant constituent, paraoxonase-1: The PREVEND prospective cohort study.
Hypertension
The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease.
Hypertension
The PON1192RR genotype is associated with a higher prevalence of arterial hypertension.
Hyperthyroidism
Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function.
Hypertriglyceridemia
Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance.
Hypertriglyceridemia
Interrelationships of serum paraoxonase, serum lipids and apolipoproteins in normal pregnancy. A longitudinal study.
Hypertriglyceridemia
Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia.
Hypertriglyceridemia
The BB-paraoxonase genotype is associated with impaired brachial reactivity after acute hypertriglyceridemia in healthy subjects.
Hypertriglyceridemia
[The paraoxonase Gln-Arg 192 polymorphism in patients with endogenous hypertriglyceridemia in Chinese population]
Hypoalbuminemia
Serum esterase activity in reactive systemic amyloidosis and its relation to amyloid A degrading activity.
Hypoalphalipoproteinemias
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage.
Hypoalphalipoproteinemias
Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.
Hypogonadism
The relationship between lipoprotein-associated phospholipase A2 with cardiovascular risk factors in testosterone deficiency.
Hypotension
Paraoxonase1 deficiency in mice is associated with hypotension and increased levels of 5,6-epoxyeicosatrienoic acid.
Hypothyroidism
Effect of levothyroxine replacement therapy on paraoxonase-1 and carotid intima-media thickness in subclinical hypothyroidism.
Hypothyroidism
Effects of Short-Term Hypothyroidism on the Lipid Transfer to High-Density Lipoprotein and Other Parameters Related to Lipoprotein Metabolism in Patients Submitted to Thyroidectomy for Thyroid Cancer.
Hypothyroidism
Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism.
Hypothyroidism
Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinical hypothyroidism.
Hypothyroidism
High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism.
Hypothyroidism
Levothyroxine improves Paraoxonase (PON-1) serum levels in patients with primary hypothyroidism: Case-control study.
Hypothyroidism
Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment.
Hypothyroidism
Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation.
Hypothyroidism
Serum oxidative stress parameters of women with hypothyroidism.
Infections
A preliminary study of paraoxonase-1 in infected patients with an indwelling central venous catheter.
Infections
Airborne particulate matter PM2.5 from Mexico City affects the generation of reactive oxygen species by blood neutrophils from asthmatics: an in vitro approach.
Infections
Cardiovascular Insufficiency, Abdominal Sepsis, and Patients' Age Are Associated with Decreased Paraoxonase-1 (PON1) Activity in Critically Ill Patients with Multiple Organ Dysfunction Syndrome (MODS).
Infections
Decreased serum paraoxonase-1 activity during intestinal nematode (Nippostrongylus brasiliensis) infection in rats.
Infections
Effect of continuous renal-replacement therapy on paraoxonase-1-related variables in patients with acute renal failure caused by septic shock.
Infections
Effect of propolis and N-acetylcysteine supplementation on lipoprotein subclasses distribution and paraoxonase 1 activity in subjects with acute respiratory infection.
Infections
Expression of PPAR? and Paraoxonase 2 Correlated with Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Infections
Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection.
Infections
High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection.
Infections
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Infections
Identification and analysis of the salt tolerant property of AHL lactonase (AiiATSAWB ) of Bacillus species.
Infections
Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide.
Infections
Nippostrongylus brasiliensis: infection decreases plasma butyrylcholinesterase activity in rats.
Infections
Paraoxonase 1, Quorum Sensing, and P. aeruginosa Infection: A Novel Model.
Infections
Paraoxonase-1 activity is related to Trichinella spiralis-induced hepatitis in rats.
Infections
Plasma Paraoxonase, Sphingosine-1-phosphate, Total Sialic Acid, and Heat Shock Protein-27 in the Liver of the Sheep Naturally Infected with Cysticercus Tenuicollis: Evidence on Pathological Changes.
Infections
PON1 activity and total oxidant status in patients with active pulmonary tuberculosis.
Infections
PON1 status in haemodialysis patients and the impact of hepatitis C infection.
Infections
Preliminary study on serum paraoxonase-1 status and chemokine (C-C motif) ligand 2 in hospitalized elderly patients with catheter-associated asymptomatic bacteriuria.
Infections
Quantitative Proteomics and Lipidomics Analysis of Endoplasmic Reticulum of Macrophage Infected with Mycobacterium tuberculosis.
Infections
Schistosoma mansoni: Effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel.
Infections
Serum ferritin and paraoxonase-1 in canine leishmaniosis.
Infections
Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis.
Infections
Serum paraoxonase and arylesterase activities in various forms of hepatitis B virus infection.
Infections
Serum platelet-activating factor acetylhydrolase and paraoxonase-1 activity in horses infected with Leptospira spp.
Infections
The Sweat Metabolome of Screen-Positive Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.
Infections
Trichinella spiralis: infection changes serum paraoxonase-1 levels, lipid profile, and oxidative status in rats.
Infections
Trypanosoma congolense: paraoxonase 1 prolongs survival of infected mice.
Infertility
Gene-environment interactions: a review of effects on reproduction and development.
Infertility
Serum tumor necrosis factor-?, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility.
Infertility
Two new loci for hybrid sterility in cultivated rice (Oryza sativa L.).
Infertility, Female
Association between Serum Paraoxonase 1 Activities (PONase/AREase) and L55M Polymorphism in Risk of Female Infertility.
Infertility, Female
Paraoxonase-1 in female infertility: a possible role against oxidative stress-induced inflammation.
Infertility, Male
Paraoxonase-1 is only present in traceable amounts in seminal fluid and does not show any relationship with male subfertility.
Infertility, Male
[Clinical value of seminal paraoxonase-1 activity evaluation in the diagnosis of male infertility].
Infertility, Male
[Correlation of the single nucleotide polymorphism rs662 of PON1 with the risk of male infertility].
Inflammatory Bowel Diseases
Paraoxonase (PON)1 192R allele carriage is associated with reduced risk of inflammatory bowel disease.
Inflammatory Bowel Diseases
Paraoxonase 1, 2 and 3 DNA variants and susceptibility to childhood inflammatory bowel disease.
Influenza, Human
High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection.
Influenza, Human
Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis.
Insulin Resistance
Adaptive response of rat pancreatic ?-cells to insulin resistance induced by monocrotophos: Biochemical evidence.
Insulin Resistance
Adiponectin is a link among inflammation, insulin resistance, and high-density lipoprotein cholesterol but is not associated with paraoxonase activity in premenopausal women.
Insulin Resistance
Association of paraoxonase-1 gene polymorphisms with insulin resistance in South Indian population.
Insulin Resistance
Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
Insulin Resistance
Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.
Insulin Resistance
Associations of HDL phospholipids and paraoxonase activity with coronary heart disease in postmenopausal women.
Insulin Resistance
Beneficial effect of low ethanol intake on the cardiovascular system: possible biochemical mechanisms.
Insulin Resistance
Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamsters.
Insulin Resistance
Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease.
Insulin Resistance
CONDITIONING FACTORS FOR HIGH CARDIOVASCULAR RISK IN PATIENTS WITH CUSHING SYNDROME.
Insulin Resistance
Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.
Insulin Resistance
Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Insulin Resistance
Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance.
Insulin Resistance
Hemodynamics and metabolism at low versus moderate altitudes.
Insulin Resistance
Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.
Insulin Resistance
Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Insulin Resistance
Paraoxonase-1 (PON1) Status in Pancreatic Cancer: Relation to Clinical Parameters.
Insulin Resistance
Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
Insulin Resistance
Paraoxonase1 (PON1) reduces insulin resistance in mice fed a high-fat diet, and promotes GLUT4 overexpression in myocytes, via the IRS-1/Akt pathway.
Insulin Resistance
Pentoxifylline mitigates renal glycoxidative stress in obese mice by inhibiting AGE/RAGE signaling and increasing glyoxalase levels.
Insulin Resistance
PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenemia.
Insulin Resistance
Q192R Paraoxonase (PON)1 Polymorphism, Insulin Sensitivity, and Endothelial Function in Essential Hypertensive Men.
Insulin Resistance
Q192R Polymorphism of Paraoxonase 1 Gene Associated with Insulin Resistance in Mexican Children.
Insulin Resistance
Role of Various Gene Expressions in Etiopathogenesis of Type 2 Diabetes Mellitus.
Insulin Resistance
Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance.
Insulin Resistance
Serum Paraoxonase-1 Levels are Significantly Decreased in the Presence of Insulin Resistance.
Insulin Resistance
The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes.
Insulin Resistance
The effect of sumac (Rhus coriaria L.) powder on insulin resistance, malondialdehyde, high sensitive C-reactive protein and paraoxonase 1 activity in type 2 diabetic patients.
Insulin Resistance
The paraoxonase PON1 promoter polymorphism C(-107)T is associated with increased serum glucose concentrations in non-diabetic patients.
Insulin Resistance
The role of chronic inflammation and Leu55Met PON1 polymorphism in the pathogenesis of polycystic ovary syndrome.
Insulin Resistance
[Combined analyses of paraoxonase-1 and IGF-2 polymorphism in polycystic ovary syndrome]
Insulin Resistance
[Smoking enhances the decrease of adiponectin level in patients with coronary artery disease, carriers of MTHFR 677T and PON1 55M alleles].
Intervertebral Disc Degeneration
Paraoxonase 1 Was Negatively Associated With Intervertebral Disc Degeneration.
Iron Deficiencies
Reduced antioxidant capacity in children with iron deficiency and iron-deficiency anemia.
Irritable Bowel Syndrome
Evaluation of paraoxonase and arylesterase activities in patients with irritable bowel syndrome.
Ischemic Stroke
Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population.
Ischemic Stroke
Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.
Ischemic Stroke
Association between paraoxonase 2 Ser311Cys polymorphism and ischemic stroke risk: a meta-analysis involving 5,008 subjects.
Ischemic Stroke
Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans.
Ischemic Stroke
Genetic polymorphisms of Chinese patients with ischemic stroke and concurrent stenoses of extracranial and intracranial vessels.
Ischemic Stroke
Interaction of folate intake and the paraoxonase Q192R polymorphism with risk of incident coronary heart disease and ischemic stroke: the atherosclerosis risk in communities study.
Ischemic Stroke
Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients.
Ischemic Stroke
Paraoxonase 1 and 2 gene variants and the ischemic stroke risk in Gran Canaria population: an association study and meta-analysis.
Ischemic Stroke
Paraoxonase 1 polymorphisms and ischemic stroke risk: A systematic review and meta-analysis.
Ischemic Stroke
Paraoxonase 192 Gln-->Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults.
Ischemic Stroke
Paraoxonase gene polymorphisms and haplotype analysis in a stroke population.
Ischemic Stroke
Paraoxonase genes and the susceptibilty to ischemic stroke.
Ischemic Stroke
Paraoxonase-1 polymorphisms and cerebral ischemic stroke: a pilot study in mexican patients.
Ischemic Stroke
Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Ischemic Stroke
Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and Ischemic Stroke: Meta-Analysis.
Ischemic Stroke
PON gene polymorphisms and ischaemic stroke: a systematic review and meta analysis.
Ischemic Stroke
Prognostic importance of paraoxonase, arylesterase and mean platelet volume efficiency in acute ischaemic stroke.
Ischemic Stroke
Rare coding variation in paraoxonase-1 is associated with ischemic stroke in the NHLBI Exome Sequencing Project.
Ischemic Stroke
Relation of Paraoxonase1, Arylesterase and Lipid Profile in Ischemic Stroke Patients.
Ischemic Stroke
Response to letter to the editor: paraoxonase genes and the susceptibility to ischemic stroke.
Ischemic Stroke
Serum paraoxonase/arylesterase activity affects outcome in ischemic stroke patients.
Ischemic Stroke
Sonographic evaluation of atherosclerosis burden in carotid arteries of ischemic stroke patients and its relation to paraoxonase 1 and 2, MTHFR and AT1R genetic variants.
Ischemic Stroke
The combined effect of paraoxonase promoter and coding region polymorphisms on the risk of arterial ischemic stroke among young adults.
Ischemic Stroke
[Relationship between Q192R polymorphisms in paraoxonase 1 gene and young ischemic stroke]
Ischemic Stroke
[The association of paraoxonase 2 gene C311S variant with ischemic stroke in Chinese type 2 diabetes mellitus patients]
Ischemic Stroke
[The effect of cigarette smoking on serum activities of paraoxonase and arylesterase in stroke patients]
Joint Diseases
HDL associated paraoxonase-1 activity correlates with systemic inflammation, disease activity and cardiovascular risk factors in psoriatic disease.
Keratoconus
Paraoxonase 1 status in keratoconus: a preliminary study of activity and polymorphism.
Ketosis
Predictive Value of Plasma Parameters in the Risk of Postpartum Ketosis in Dairy Cows.
Ketosis
Serum paraoxonase-1 activity in tail and mammary veins of ketotic dairy cows.
Kidney Diseases
Can keto/amino acids reduce oxidative stress in peritoneal dialysis patients with hypoalbuminemia?
Kidney Diseases
Paraoxonase 1 deficiency and hyperhomocysteinemia alter the expression of mouse kidney proteins involved in renal disease.
Kidney Failure, Chronic
Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.
Kidney Failure, Chronic
Activity of paraoxonase 1 (PON1) on HDL2 and HDL3 subclasses in renal disease.
Kidney Failure, Chronic
Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
Kidney Failure, Chronic
Effect of nutritional status on human paraoxonase-1 activity in patients with chronic kidney disease.
Kidney Failure, Chronic
Increased carbamylation level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function.
Kidney Failure, Chronic
Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis.
Kidney Failure, Chronic
Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
Kidney Failure, Chronic
Low High-Density Lipoprotein Cholesterol Is Not Responsible for Decreased Paraoxonase Activity in Chronic Renal Failure.
Kidney Failure, Chronic
Paraoxonase 1 in chronic kidney failure.
Kidney Failure, Chronic
Paraoxonase activity and antibodies to oxidized-LDL in chronic renal failure patients on renal replacement therapy.
Kidney Failure, Chronic
Paraoxonase activity stimulation by salts is higher in chronic renal failure patients than in controls.
Kidney Failure, Chronic
Paraoxonase, anti-oxidant response and oxidative stress in children with chronic renal failure.
Kidney Failure, Chronic
Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
Kidney Failure, Chronic
Paraoxonase-1 and ischemia-modified albumin in patients with end-stage renal disease.
Kidney Failure, Chronic
Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
Kidney Failure, Chronic
Paraoxonase: Its antiatherogenic role in chronic renal failure.
Kidney Failure, Chronic
Renal cortical thickness and PON1 activity both decrease in chronic renal failure.
Kidney Failure, Chronic
Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.
Kidney Failure, Chronic
Serum paraoxonase activity and protein thiols in chronic renal failure patients.
Kidney Failure, Chronic
The free fraction of paraoxonase 1 is not increased in patients with end stage renal disease undergoing hemodialysis.
Kidney Failure, Chronic
The Protective Role of Adiponectin for Lipoproteins in End-Stage Renal Disease Patients: Relationship with Diabetes and Body Mass Index.
Kidney Failure, Chronic
The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia.
Kidney Failure, Chronic
[From organophosphate compound toxicity to atherosclerosis: role of paraoxonase 1]
Language Development Disorders
Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders.
Laryngeal Neoplasms
Alterations in oxidative stress markers in laryngeal carcinoma patients.
Lecithin Cholesterol Acyltransferase Deficiency
Low A-esterase activity in serum of patients with fish-eye disease.
Lecithin Cholesterol Acyltransferase Deficiency
Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration.
Leiomyoma
Oxidative stress and prolidase activity in women with uterine fibroids.
Leiomyoma
Q192R variant in paraoxonase 1 gene confers susceptibility to leiomyoma.
Leishmaniasis
Influence of domperidone supplementation on short-term changes in C-reactive protein and paraoxonase-1 in dogs with leishmaniasis undergoing meglumine antimoniate and allopurinol therapy.
Leishmaniasis
Paraoxonase activity as a tool for clinical monitoring of dogs treated for canine leishmaniasis.
Leukemia, Lymphocytic, Chronic, B-Cell
Paraoxonase 1 (PON1) Q192R and L55M Polymorphisms as Potential Predisposition Factors for Chronic Lymphocytic Leukemia.
Leukemia, Lymphocytic, Chronic, B-Cell
Q192R and L55M Polymorphisms of Paraoxonase 1 Gene in Chronic Myelogenous Leukemia and Chronic Lymphocytic Leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Q192R and L55M Polymorphisms of Paraoxonase 1 Gene in Chronic Myelogenous Leukemia and Chronic Lymphocytic Leukemia.
Leukemia, Myeloid, Acute
The activities of serum paraoxonase and arylesterase and lipid profile in acute myeloid leukemia: preliminary results.
Lipid Metabolism Disorders
Association of a polymorphism in PON-1 gene with steroid-induced osteonecrosis of femoral head in Chinese Han population.
Lipodystrophy
Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy.
Liver Cirrhosis
2-Oxo-1,3-dioxoles as specific substrates for measurement of arylesterase activity.
Liver Cirrhosis
Combination of serum paraoxonase/arylesterase 1 and antithrombin-III is a promising non-invasion biomarker for discrimination of AFP-negative HCC versus liver cirrhosis patients.
Liver Cirrhosis
Cytokines, paraoxonase-1, periostin and non-invasive liver fibrosis scores in patients with non-alcoholic fatty liver disease and persistently elevated aminotransferases: A pilot study.
Liver Cirrhosis
ELISA using monoclonal antibody to human serum arylesterase.
Liver Cirrhosis
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases.
Liver Cirrhosis
Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model.
Liver Diseases
A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease.
Liver Diseases
Açai (Euterpe oleracea Mart.) Upregulates Paraoxonase 1 Gene Expression and Activity with Concomitant Reduction of Hepatic Steatosis in High-Fat Diet-Fed Rats.
Liver Diseases
Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
Liver Diseases
Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease.
Liver Diseases
Association of Paraoxonase 1 Gene Polymorphisms With the Risk of Hepatitis B Virus-related Liver Diseases in a Guangxi Population: A Case-control Study.
Liver Diseases
Baseline and salt-stimulated paraoxonase and arylesterase activities in patients with chronic liver disease: relation to disease severity.
Liver Diseases
Baseline and Salt-stimulated Paraoxonase and Arylesterase Activities in Patients with Chronic Liver Disease: Relation with Disease Severity.
Liver Diseases
Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors.
Liver Diseases
Cytokines, paraoxonase-1, periostin and non-invasive liver fibrosis scores in patients with non-alcoholic fatty liver disease and persistently elevated aminotransferases: A pilot study.
Liver Diseases
Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities.
Liver Diseases
Interrelationships between paraoxonase-1 and monocyte chemoattractant protein-1 in the regulation of hepatic inflammation.
Liver Diseases
Involvement of xanthine oxidase and paraoxonase 1 in the process of oxidative stress in nonalcoholic fatty liver disease.
Liver Diseases
New chemiluminescent substrates of paraoxonase 1 with improved specificity: synthesis and properties.
Liver Diseases
Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.
Liver Diseases
Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic Fatty liver disease.
Liver Diseases
Paraoxonase activity in sera of patients with non-alcoholic fatty liver disease.
Liver Diseases
Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Liver Diseases
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases.
Liver Diseases
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease.
Liver Diseases
Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease.
Liver Diseases
Serum esterase activity in reactive systemic amyloidosis and its relation to amyloid A degrading activity.
Liver Diseases
Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B.
Liver Diseases
Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol.
Liver Diseases
Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.
Liver Diseases
Serum paraoxonase and arylesterase activities in Iranian patients with nonalcoholic fatty liver disease.
Liver Diseases
Serum paraoxonase levels in patients with acute liver disease.
Liver Diseases
Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease.
Liver Diseases
Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
Liver Diseases
[Arylesterase isoenzymes in the diagnosis of liver diseases]
Liver Diseases, Alcoholic
Identification and preliminary validation of novel biomarkers of acute hepatic ischaemia/reperfusion injury using dual-platform proteomic/degradomic approaches.
Liver Diseases, Alcoholic
Serum paraoxonase-1 in chronic alcoholics: relationship with liver disease.
Liver Neoplasms
Hypermethylation reduces the expression of PNPLA7 in hepatocellular carcinoma.
Liver Neoplasms
Transcriptomic characterization reveals prognostic molecular signatures of sorafenib resistance in hepatocellular carcinoma.
Low Tension Glaucoma
Higher serum lipids and oxidative stress in patients with normal tension glaucoma, but not pseudoexfoliative glaucoma.
Lung Diseases
Assessing the relationship of paraoxonase-1 Q192R polymorphisms and the severity of lung disease in SM-exposed patients.
Lung Diseases
Serum paraoxonase and arylesterase activities in patients with pulmonary tuberculosis.
Lung Neoplasms
Association of genetic polymorphisms in the paraoxonase 1 gene with the risk and prognosis of non-small cell lung cancer in chinese han population.
Lung Neoplasms
Interactions between Paraoxonase 1 Genetic Polymorphisms and Smoking and Their Effects on Oxidative Stress and Lung Cancer Risk in a Korean Population.
Lung Neoplasms
Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells.
Lung Neoplasms
Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population.
Lung Neoplasms
Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.
Lung Neoplasms
Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy.
Lung Neoplasms
[Effects of oxidative DNA damage induced by polycyclic aromatic hydrocarbons and genetic polymorphism of the paraoxonase-1 (PON1) gene on lung cancer]
Lupus Erythematosus, Systemic
Anti-apolipoprotein A-I antibodies and paraoxonase 1 activity in Systemic Lupus Erythematosus.
Lupus Erythematosus, Systemic
Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
Lupus Erythematosus, Systemic
Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.
Lupus Erythematosus, Systemic
Associations between paraoxonase-1 and systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Genetic variation in the paraoxonase-3 (PON3) gene is associated with serum PON1 activity.
Lupus Erythematosus, Systemic
High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Paraoxonase (PON1) 55 Polymorphism and Association with Systemic Lupus Erythematosus.
Lupus Erythematosus, Systemic
Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
Lupus Erythematosus, Systemic
Synergism between apolipoprotein E ?4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Lymphocytosis
Immunopotentiating activity of abrin, a lectin from Abrus precatorius Linn.
Macular Degeneration
Association between the L55M and Q192R polymorphisms of the paraoxonase-1 gene and age-related macular degeneration: a meta-analysis.
Macular Degeneration
ASSOCIATION OF PARAOXONASE 1 L55M AND Q192R SINGLE-NUCLEOTIDE POLYMORPHISMS WITH AGE-RELATED MACULAR DEGENERATION.
Macular Degeneration
Association of the M55L and Q192R paraoxonase gene polymorphisms with age-related macular degeneration.
Macular Degeneration
Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration.
Macular Degeneration
Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration.
Macular Degeneration
Regulatory regions of the paraoxonase 1 (PON1) gene are associated with neovascular age-related macular degeneration (AMD).
Macular Degeneration
Serum paraoxonase 1 activity and lipid peroxidation levels in patients with age-related macular degeneration.
Malnutrition
Leptin and adiponectin as new markers of undernutrition in cancer.
Malnutrition
Paraoxonase, total antioxidant activity and peroxide levels in marasmic children: relationships with leptin.
Mania
Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach.
Mastitis
Paraoxonase 1 in bovine milk and blood as marker of subclinical mastitis caused by Staphylococcus aureus.
Mastitis
Relationship between California mastitis test reaction and leucocyte count, catalase activity, and A-esterase activity of milk from opposite quarters.
Meningioma
Paraoxonase 192 gene polymorphism and serum paraoxonase activity in high grade gliomas and meningiomas.
Meningioma
Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma.
Mesenteric Ischemia
Early Elevation of Cell-free DNA After Acute Mesenteric Ischemia in Rats.
Metabolic Syndrome
ABCA1 gene R1587K polymorphism could be associated with metabolic syndrome and increased plasma triglyceride concentration in adults from northern Mexico.
Metabolic Syndrome
Antioxidant paraoxonase 1 activity in the metabolic syndrome.
Metabolic Syndrome
Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet.
Metabolic Syndrome
Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome.
Metabolic Syndrome
Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease.
Metabolic Syndrome
Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.
Metabolic Syndrome
Circulating levels of adiponectin, orexin-A, ghrelin and the antioxidant paraoxonase-1 in metabolic syndrome.
Metabolic Syndrome
Cross-sectional correlates of paraoxonase 1 and soluble intercellular adhesion molecule-1 in metabolic syndrome patients with and without diabetes.
Metabolic Syndrome
Does metformin increase paraoxonase activity in patients with the metabolic syndrome? Additional data from the MEFISTO study.
Metabolic Syndrome
HDL associated paraoxonase-1 activity correlates with systemic inflammation, disease activity and cardiovascular risk factors in psoriatic disease.
Metabolic Syndrome
Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome.
Metabolic Syndrome
Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.
Metabolic Syndrome
Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.
Metabolic Syndrome
Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation.
Metabolic Syndrome
Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.
Metabolic Syndrome
Paraoxonase 1 (PON1) in French HIV-Infected Patients under Antiretroviral Therapy: Relationship with the Metabolic Syndrome and Inflammation.
Metabolic Syndrome
Paraoxonase 1 genotype-phenotype correlation in patients with metabolic syndrome.
Metabolic Syndrome
Paraoxonase activity in metabolic syndrome in children and adolescents.
Metabolic Syndrome
Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome.
Metabolic Syndrome
Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
Metabolic Syndrome
Paraoxonase-1 promoter polymorphism C--107T and serum apolipoprotein AI interact to modulate serum paraoxonase-1 status.
Metabolic Syndrome
Persistent elevation of paraoxonase-1 specific enzyme activity after weight reduction in obese non-diabetic men with metabolic syndrome.
Metabolic Syndrome
Positive correlation of paraoxonase 1 (PON1) activity with serum insulin level and HOMA-IR in dementia. A possible advantageous role of PON1 in dementia development.
Metabolic Syndrome
Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.
Metabolic Syndrome
Serum paraoxonase and arylesterase activities in metabolic syndrome in Zahedan, southeast Iran.
Metabolic Syndrome
Serum paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/without metabolic syndrome.
Metabolic Syndrome
Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome.
Metabolic Syndrome
Small, dense lipoprotein particles and reduced paraoxonase-1 in patients with the metabolic syndrome.
Metabolic Syndrome
Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
Metabolic Syndrome
The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome.
Metabolic Syndrome
The relationship between paraoxonase-1 activity and coronary artery disease in patients with metabolic syndrome.
Metabolic Syndrome
[Sedentary lifestyle: physical activity duration versus percentage of energy expenditure]
Microvascular Angina
Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers.
Migraine Disorders
Paraoxonase 1 (PON1) polymorphisms and risk for migraine.
Migraine Disorders
Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
Mixed Connective Tissue Disease
Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.
Mixed Connective Tissue Disease
Evaluation of paraoxonase activity in patients with mixed connective tissue disease.
Mixed Connective Tissue Disease
Increased levels of anti-heat-shock protein 60 (anti-Hsp60) indicate endothelial dysfunction, atherosclerosis and cardiovascular diseases in patients with mixed connective tissue disease.
Motor Neuron Disease
Neuropathy target esterase gene mutations cause motor neuron disease.
Motor Neuron Disease
Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients.
Multiple Myeloma
Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma.
Multiple Myeloma
Decreased HDL-dependent paraoxonase and arylesterase enzyme activity may indicate a worse prognosis in multiple myeloma.
Multiple Myeloma
Serum 8-isoprostane levels and paraoxonase 1 activity in patients with stage I multiple myeloma.
Multiple Sclerosis
Association between serum paraoxonase 1 activity and its polymorphisms with multiple sclerosis: a systematic review.
Multiple Sclerosis
Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity.
Multiple Sclerosis
Lack of association between paraoxonase 1 Q192R polymorphism and multiple sclerosis in relapse phase: A case-control study.
Multiple Sclerosis
Paraoxonase 1 activity in different types of multiple sclerosis.
Multiple Sclerosis
Paraoxonase 1 activity in multiple sclerosis patients during mitoxantrone therapy.
Multiple Sclerosis
Paraoxonase 1 Polymorphisms Are Not Related with the Risk for Multiple Sclerosis.
Multiple Sclerosis
Polymorphisms of paraoxonase 1 and 2 genes and the risk of multiple sclerosis in the Polish population.
Multiple Sclerosis
Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
Multiple Sclerosis, Relapsing-Remitting
Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
Muscular Diseases
Histopathology is required to identify and characterize myopathies in high-throughput phenotype screening of genetically engineered mice.
Muscular Diseases
[Muscular, plasma and globular cholinesterases and arylesterase in experimental myopathy in rabbits due to diet deficient in choline]
Myocardial Infarction
Acetylcholine esterase protects LDL against oxidation.
Myocardial Infarction
Addressing the link between paraoxonase-1 gene variants and the incidence of early onset myocardial infarction.
Myocardial Infarction
Association between paraoxonase-1 and paraoxonase-2 polymorphisms and the risk of acute myocardial infarction.
Myocardial Infarction
Cardiovascular risk factors in elderly normolipidemic acute myocardial infarct patients--a case controlled study from India.
Myocardial Infarction
Characterization of paraoxonase activity in pericardial fluid: usefulness as a marker of coronary disease.
Myocardial Infarction
Clinical and Genetic Association of Serum Paraoxonase and Arylesterase Activities With Cardiovascular Risk.
Myocardial Infarction
Decrease of serum paraoxonase activity in chronic renal failure.
Myocardial Infarction
Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxonase gene.
Myocardial Infarction
Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.
Myocardial Infarction
Effect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarction.
Myocardial Infarction
Interactions and associations of paraoxonase gene cluster polymorphisms with myocardial infarction in a Pakistani population.
Myocardial Infarction
Oxidative Stress and Paraoxonase 1 Activity Predict Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Myocardial Infarction
Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.
Myocardial Infarction
Paraoxonase (PON1) Gene Polymorphisms in Fabry Disease: Correlation with Renal Disease.
Myocardial Infarction
Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk.
Myocardial Infarction
Paraoxonase 1 Polymorphisms and Risk of Myocardial Infarction in Women and Men.
Myocardial Infarction
Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes.
Myocardial Infarction
Paraoxonase gene Q192R & L55M polymorphisms in Indians with acute myocardial infarction & association with oxidized low density lipoprotein.
Myocardial Infarction
Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease.
Myocardial Infarction
Paraoxonase-1 55 LL Genotype Is Associated with No ST-Elevation Myocardial Infarction and with High Levels of Myoglobin.
Myocardial Infarction
Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow.
Myocardial Infarction
Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study.
Myocardial Infarction
Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction.
Myocardial Infarction
Relationship between Paraoxonase-1 and Arylesterase Enzyme Activities and SYNTAX I and II Scores in Patients with ST-Elevation Myocardial Infarction.
Myocardial Infarction
Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study.
Myocardial Infarction
Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus. The REGICOR Investigators.
Myocardial Infarction
Serum arylesterase (paraoxonase) activity following myocardial infarction.
Myocardial Infarction
Smoking is associated with reduced serum paraoxonase, antioxidants and increased oxidative stress in normolipidaemic acute myocardial infarct patients.
Myocardial Infarction
The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study.
Myocardial Infarction
The influence of renal function on the association of rs854560 polymorphism of paraoxonase 1 gene with long-term prognosis in patients after myocardial infarction.
Myocardial Infarction
The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease.
Myocardial Infarction
The paraoxonase L55M and Q192R gene polymorphisms and myocardial infarction in a Tunisian population.
Myocardial Infarction
Tobacco smoking modifies association between Gln-Arg192 polymorphism of human paraoxonase gene and risk of myocardial infarction.
Myocardial Infarction
[Association between paraoxonase-1 and paraoxonase-2 polymorphisms and the risk of acute myocardial infarction]
Myocardial Infarction
[Genetic risk factors for development of myocardial infarction in young men living in North-West region of Russia]
Myocardial Ischemia
Cytochrome 2C19 and paraoxonase-1 polymorphisms and clopidogrel resistance in ischemic heart disease patients.
Myocardial Ischemia
Effect of statins on serum apolipoprotein j and paraoxonase-1 levels in patients with ischemic heart disease undergoing coronary angiography.
Myocardial Ischemia
Ischemic heart disease as deficiency disease.
Myocardial Ischemia
Paraoxonase activity following exercise-based cardiac rehabilitation program.
Myocardial Ischemia
Paraoxonase1, its Q192R polymorphism and HDL-cholesterol in relation to intensive cardiac care unit stay in ischemic heart disease.
Nasal Polyps
Serum paraoxonase, arylesterase activity, and oxidative status in patients with nasal polyp.
Nematode Infections
An atherogenic lipid profile with low serum paraoxonase-1 activity during nematode infection in rats.
Nematode Infections
Decreased serum paraoxonase-1 activity during intestinal nematode (Nippostrongylus brasiliensis) infection in rats.
Neonatal Sepsis
Total Antioxidan Level, Total Oxidan Level and Serum Paraoxonase-1 Levels in Neonatal Sepsis.
Neoplasm Metastasis
Adenocarcinoma of the colon with choriocarcinoma in its metastases.
Neoplasm Metastasis
Collapsing the Metabolic PON2zi Scheme in Pancreatic Ductal Adenocarcinoma.
Neoplasm Metastasis
Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival.
Neoplasm Metastasis
Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
Neoplasms
A meta-analysis of the relationship between paraoxonase 1 polymorphisms and cancer.
Neoplasms
Accelerated atherosclerosis in rheumatoid arthritis.
Neoplasms
Age-Related Adverse Inflammatory and Metabolic Changes Begin Early in Adulthood.
Neoplasms
Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice.
Neoplasms
Arylesterase isoenzymes and activity in normal healthy adults and in patients with cancer and with other diseases.
Neoplasms
Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study.
Neoplasms
Association between L55M polymorphism in Paraoxonase 1 and cancer risk: a meta-analysis based on 21 studies.
Neoplasms
Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
Neoplasms
Association of cadmium, lead and mercury with paraoxonase 1 activity in women.
Neoplasms
Association of candidate gene polymorphisms with diabetic retinopathy in Chinese patients with type 2 diabetes.
Neoplasms
Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.
Neoplasms
Association of Paraoxonase 1 Gene Polymorphisms With the Risk of Hepatitis B Virus-related Liver Diseases in a Guangxi Population: A Case-control Study.
Neoplasms
Association of Paraoxonase-1(Q192R and L55M) Gene Polymorphisms and Activity with Colorectal Cancer and Effect of Surgical Intervention.
Neoplasms
Association of PON1-L55M Genetic Variation and Breast Cancer Risk: A Case-Control Trial.
Neoplasms
Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus.
Neoplasms
Biochemical effects, hypolipidemic and anti-inflammatory activities of Artemisia vulgaris extract in hypercholesterolemic rats.
Neoplasms
Common genetic variants in the myeloperoxidase and paraoxonase genes and the related cancer risk: a review.
Neoplasms
Complex Coronary Instent Chronic Total Occlusion Lesions: Oxidative Stress, Inflammation, and Coronary Stent Lengths.
Neoplasms
Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment.
Neoplasms
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment.
Neoplasms
Crosstalk Between Adipokines and Paraoxonase 1: A New Potential Axis Linking Oxidative Stress and Inflammation.
Neoplasms
Cytokines, paraoxonase-1, periostin and non-invasive liver fibrosis scores in patients with non-alcoholic fatty liver disease and persistently elevated aminotransferases: A pilot study.
Neoplasms
Decreased HDL-dependent paraoxonase and arylesterase enzyme activity may indicate a worse prognosis in multiple myeloma.
Neoplasms
Differential effects of paraoxonase 1 (PON1) polymorphisms on cancer risk: evidence from 25 published studies.
Neoplasms
Do CO2 and oxidative stress induce cancer?: a brief study about the evaluation of PON 1, CAT, CA and XO enzyme levels on head and neck cancer patients.
Neoplasms
Effect of dapagliflozin and/or L-arginine on solid tumor model in mice: The interaction between nitric oxide, transforming growth factor-beta 1, autophagy, and apoptosis.
Neoplasms
Effects of improved fat meat products consumption on emergent cardiovascular disease markers of male volunteers at cardiovascular risk.
Neoplasms
Efficacy of oral rosuvastatin intervention on HDL and its associated proteins in men with type 2 diabetes mellitus.
Neoplasms
Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Neoplasms
Epigenetic patterns of two gene promoters (TNF-? and PON) in stroke considering obesity condition and dietary intake.
Neoplasms
Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival.
Neoplasms
Exogenous supplement of N-acetylneuraminic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice.
Neoplasms
Expression and Intracellular Localization of Paraoxonase 2 in Different Types of Malignancies.
Neoplasms
Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients.
Neoplasms
Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease.
Neoplasms
Hesperidin attenuates altered redox homeostasis in an experimental hyperlipidaemic model of rat.
Neoplasms
Histological and biochemical investigation of the renoprotective effects of metformin in diabetic and prostate cancer model.
Neoplasms
Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1beta and tumor necrosis factor-alpha, but is upregulated by interleukin-6.
Neoplasms
Increased inflammatory markers with altered antioxidant status persist after clinical recovery from severe sepsis: a correlation with low HDL cholesterol and albumin.
Neoplasms
Increased Levels of Plasma Tumor Necrosis Factor-? Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity.
Neoplasms
Indolyl-chalcone derivatives induce hepatocellular carcinoma cells apoptosis through oxidative stress related mitochondrial pathway in vitro and in vivo.
Neoplasms
Inflammation and Oxidative Stress in Deficit Schizophrenia.
Neoplasms
Influence of heredity on human sensitivity to environmental chemicals.
Neoplasms
Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.
Neoplasms
Investigation of anti-inflammatory effects of bee venom in experimentally induced adjuvant arthritis.
Neoplasms
Is there a relation between genetic susceptibility with cancer? A study about paraoxanase (PON1) enzyme activity in breast cancer cases.
Neoplasms
Liver X Receptor (LXR)-regulated Genes of Cholesterol Trafficking and Breast Cancer Severity.
Neoplasms
Molecular and biochemical evidence on the protective effects of embelin and carnosic acid in isoproterenol-induced acute myocardial injury in rats.
Neoplasms
N-(3-oxo-acyl) homoserine lactone inhibits tumor growth independent of Bcl-2 proteins.
Neoplasms
Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis.
Neoplasms
New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.
Neoplasms
p-Cymene Modulate Oxidative Stress and Inflammation in Murine Macrophages: Potential Implication in atherosclerosis.
Neoplasms
Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.
Neoplasms
Paraoxonase 1 (PON1) Q192R Gene Polymorphism and Cancer Risk: A Meta-Analysis Based on 30 Publications.
Neoplasms
Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes - connection with inflammation.
Neoplasms
Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer.
Neoplasms
Paraoxonase 2 Serves a Proapopotic Function in Mouse and Human Cells in Response to the Pseudomonas aeruginosa Quorum-sensing Molecule N-(3-Oxododecanoyl)-homoserine Lactone.
Neoplasms
Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells.
Neoplasms
Paraoxonase-1 (PON1) Status in Pancreatic Cancer: Relation to Clinical Parameters.
Neoplasms
Paraoxonase-1 activity in patients with cancer: A systematic review and meta-analysis.
Neoplasms
Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.
Neoplasms
Persistent organic pollutants distribution in lipoprotein fractions in relation to cardiovascular disease and cancer.
Neoplasms
Pharmacological interactions of paraoxonase 1 (PON1): A HDL-bound antiatherogenic enzyme.
Neoplasms
Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects.
Neoplasms
Pro-inflammatory Mediators and Oxidative Stress: Therapeutic Markers for Recurrent Angina Pectoris after Coronary Artery Stenting in Elderly Patients.
Neoplasms
Regulatory effects of dioxin-like and non-dioxin-like PCBs and other AhR ligands on the antioxidant enzymes paraoxonase 1/2/3.
Neoplasms
Relationship between the paraoxonase 1 (PON1) M55L and Q192R polymorphisms and lymphohaematopoietic cancers in a Greek agricultural population.
Neoplasms
Relationship of classical and non-classical risk factors with genetic variants relevant to coronary heart disease.
Neoplasms
Serum arylesterase and paraoxonase activities in patients with ovarian tumors.
Neoplasms
Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer.
Neoplasms
Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
Neoplasms
Serum Paraoxonase-1 Concentration as a Potential Predictor of Urinary Bladder Cancer Recurrence. A Five Year Follow-Up Study.
Neoplasms
Serum tumor necrosis factor-?, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility.
Neoplasms
Single nucleotide polymorphisms in obesity-related genes and all-cause and cause-specific mortality: a prospective cohort study.
Neoplasms
The investigation of the relationships of demodex density with inflammatory response and oxidative stress in rosacea.
Neoplasms
The Role of Oxidative Stress and Inflammatory Mediators in Benign Paroxysmal Positional Vertigo.
Neoplasms
The role of paraoxonase in cancer.
Neoplasms
Therapeutic effect of simvastatin on DMBA-induced breast cancer in mice.
Neoplasms
Transcriptomic characterization reveals prognostic molecular signatures of sorafenib resistance in hepatocellular carcinoma.
Neoplasms
Vascular reactivity and biomarkers of endothelial function in healthy subjects exposed to acute hypobaric hypoxia.
Neoplasms
[Studies on serum esterases in cancer. Cholinesterase and arylesterase activity]
Nephrotic Syndrome
Evaluation of paraoxonase activity in children with nephrotic syndrome.
Nephrotic Syndrome
Paraoxonase Activity and Lipid Profile in Paediatric Nephrotic Syndrome: A Cross-sectional Study.
Nephrotic Syndrome
Paraoxonase, total antioxidant response, and peroxide levels in children with steroid-sensitive nephrotic syndrome.
Nephrotic Syndrome
Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
Nervous System Diseases
Paraoxonase 1 in neurological disorders.
Nervous System Diseases
Pharmacological interactions of paraoxonase 1 (PON1): A HDL-bound antiatherogenic enzyme.
Neural Tube Defects
Amniotic fluid paraoxonase-1 activity, thyroid hormone concentration and oxidant status in neural tube defects.
Neurodegenerative Diseases
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases.
Neurodegenerative Diseases
Paraoxonase 1 in neurological disorders.
Neurodegenerative Diseases
Paraoxonase Role in Human Neurodegenerative Diseases.
Neurodegenerative Diseases
Role of paraoxonase 1 (PON1) in organophosphate metabolism: Implications in neurodegenerative diseases.
Neurologic Manifestations
Activity of Paraoxonase/Arylesterase and Butyrylcholinesterase in Peripheral Blood of Gulf War Era Veterans With Neurologic Symptom Complexes or Post-Traumatic Stress Disorder.
Neurologic Manifestations
Activity of Paraoxonase/Arylesterase and Butyrylcholinesterase in Peripheral Blood of Gulf War Era Veterans With Neurologic Symptom Complexes or Post-Traumatic Stress Disorder: Erratum.
Neurologic Manifestations
Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans.
Newcastle Disease
Ameliorative effect of synthetic ?-aminobutyric acid (GABA) on performance traits, antioxidant status and immune response in broiler exposed to cyclic heat stress.
Non-alcoholic Fatty Liver Disease
Açai (Euterpe oleracea Mart.) Upregulates Paraoxonase 1 Gene Expression and Activity with Concomitant Reduction of Hepatic Steatosis in High-Fat Diet-Fed Rats.
Non-alcoholic Fatty Liver Disease
Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors.
Non-alcoholic Fatty Liver Disease
Cytokines, paraoxonase-1, periostin and non-invasive liver fibrosis scores in patients with non-alcoholic fatty liver disease and persistently elevated aminotransferases: A pilot study.
Non-alcoholic Fatty Liver Disease
Fatty Liver Is Associated with Recurrent Bacterial Infections Independent of Metabolic Syndrome.
Non-alcoholic Fatty Liver Disease
Involvement of xanthine oxidase and paraoxonase 1 in the process of oxidative stress in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.
Non-alcoholic Fatty Liver Disease
Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic Fatty liver disease.
Non-alcoholic Fatty Liver Disease
Paraoxonase activity in sera of patients with non-alcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Non-alcoholic Fatty Liver Disease
Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease.
Non-alcoholic Fatty Liver Disease
Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
Non-alcoholic Fatty Liver Disease
Protective effect of soy isoflavones and activity levels of plasma paraoxonase and arylesterase in the experimental nonalcoholic steatohepatitis model.
Non-alcoholic Fatty Liver Disease
Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol.
Non-alcoholic Fatty Liver Disease
Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents.
Non-alcoholic Fatty Liver Disease
Serum paraoxonase and arylesterase activities in Iranian patients with nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
Non-alcoholic Fatty Liver Disease
Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome.
Non-alcoholic Fatty Liver Disease
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
Non-ST Elevated Myocardial Infarction
Association between paraoxonase 1 activity and severity of coronary artery disease in patients with acute coronary syndromes.
Nutrition Disorders
Effect of homocysteinylation on high density lipoprotein physico-chemical properties.
Obesity
African walnut (Tetracarpidium conophorum) modulates hepatic lipid accumulation in obesity via reciprocal actions on HMG-CoA reductase and paraoxonase.
Obesity
Alteration of PON1 Activity in Adult and Childhood Obesity and Its Relation to Adipokine Levels.
Obesity
Associations of PON1 and genetic ancestry with obesity in early childhood.
Obesity
Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding.
Obesity
Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial.
Obesity
Genotypes of Common Polymorphisms in the PON1 Gene Associated with Paraoxonase Activity as Cardiovascular Risk Factor.
Obesity
Letter to the editor: methodological approach to paraoxonase-1 activity in obesity complicated by obstructive sleep apnea.
Obesity
Molecular characterization and expression analysis of the porcine paraoxonase 3 (PON3) gene.
Obesity
Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation.
Obesity
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications.
Obesity
Overweight and Obesity in Polycystic Ovary Syndrome: Association with Inflammation, Oxidative Stress and Dyslipidemia.
Obesity
Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.
Obesity
Paraoxonase 1: The Lectin-Like Oxidized LDL Receptor Type I and Oxidative Stress in the Blood of Men with Type II Obesity.
Obesity
Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
Obesity
Paraoxonase-1 and adipokines: Potential links between obesity and atherosclerosis.
Obesity
Pharmacological interactions of paraoxonase 1 (PON1): A HDL-bound antiatherogenic enzyme.
Obesity
Q192R Polymorphism of Paraoxonase 1 Gene Associated with Insulin Resistance in Mexican Children.
Obesity
Q192R polymorphism of the paraoxonase-1 gene as a risk factor for obesity in Portuguese women.
Obesity
Relation of Paraoxonase 1 Activity with Biochemical Variables, Brachial Artery Intima-Media Thickness in Patients with Diabetes with or without Obesity.
Obesity
Relationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot study.
Obesity
Serum concentrations of trace elements and their relationships with paraoxonase-1 in morbidly obese women.
Obesity
Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance.
Obesity
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1.
Obesity, Abdominal
Anti-atherogenic properties of high-density lipoproteins in psychiatric patients before and after two months of atypical anti-psychotic therapy.
Obesity, Abdominal
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1.
Obesity, Abdominal
The Relation between Eating Habits and Abdominal Fat, Anthropometry, PON1 and IL-6 Levels in Patients with Multiple Sclerosis.
Osteoarthritis
Assessment of paraoxonase activities in patients with knee osteoarthritis.
Osteoarthritis
Effects of Oral Hyaluronic Acid Administration in Dogs Following Tibial Tuberosity Advancement Surgery for Cranial Cruciate Ligament Injury.
Osteoarthritis
Evaluation of selected parameters of lipid peroxidation and paraoxonase activity in blood of patients with joint osteoarthritis.
Osteoarthritis
Expression of proteins in serum, synovial fluid, synovial membrane, and articular cartilage samples obtained from dogs with stifle joint osteoarthritis secondary to cranial cruciate ligament disease and dogs without stifle joint arthritis.
Osteoarthritis
The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation.
Osteoarthritis, Knee
Assessment of paraoxonase activities in patients with knee osteoarthritis.
Osteoarthritis, Knee
Paraoxonase-1 activity and oxidative status in patients with knee osteoarthritis and their relationship with radiological and clinical parameters.
Osteomyelitis
The activity of paraoxonase and arylesterase in patients with osteomyelitis.
Osteonecrosis
Paraoxonase 1 gene polymorphisms in patients with osteonecrosis of the femoral head with and without cerebral white matter lesions.
Osteonecrosis
The genetic association between PON1 polymorphisms and osteonecrosis of femoral head: A case-control study.
Osteoporosis
Association of serum paraoxonase concentration with serum lipid levels and bone mineral density measurements in early postmenopausal women.
Osteoporosis
Effects of paraoxonase 1 on the cytodifferentiation and mineralization of periodontal ligament cells.
Osteoporosis
Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
Osteoporosis, Postmenopausal
HDL-Associated Paraoxonase 1 as a Bridge between Postmenopausal Osteoporosis and Cardiovascular Disease.
Osteosarcoma
Paraoxonase 1 192 and 55 polymorphisms in osteosarcoma.
Otitis Media
Serum paraoxonase and arylesterase activities in patients with chronic otitis media.
Otosclerosis
Oxidative stress in otosclerosis.
Ovarian Neoplasms
Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer.
Ovarian Neoplasms
Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
Overweight
Changes on the physiological lactonase activity of serum paraoxonase 1 by a diet intervention for weight loss in healthy overweight and obese women.
Overweight
Effect of Quercetin on Paraoxonase 2 Levels in RAW264.7 Macrophages and in Human Monocytes--Role of Quercetin Metabolism.
Overweight
Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial.
Overweight
P074. Circulating adipokynes and Paraoxonase-1 activity in overweight Crohn's disease patients.
Overweight
Paraoxonase (PON)-1 activity in overweight and obese children and adolescents: association with obesity-related inflammation and oxidative stress.
Overweight
Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.
Overweight
Paraoxonase 1 Activity in Chylomicrons and VLDL: The Effect of Type 2 Diabetes and Meals Rich in Saturated Fat and Oleic Acid.
Overweight
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women.
Overweight
Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyperlipidaemia.
Overweight
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications.
Pancreatic Neoplasms
Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
Pancreatic Neoplasms
Paraoxonase-1 (PON1) Status in Pancreatic Cancer: Relation to Clinical Parameters.
Pancreatitis
Association between antioxidants and mild acute pancreatitis.
Pancreatitis
Decreases in Paraoxonase-1 Activities Promote a Pro-inflammatory Effect of Lipids Peroxidation Products in Non-smoking and Smoking Patients with Acute Pancreatitis.
Pancreatitis
Serum paraoxonase (a high-density lipoprotein-associated lipophilic antioxidant) activity and lipid profile in experimental acute pancreatitis.
Pancreatitis, Chronic
Paraoxonase 1-192Q allele is a risk factor for idiopathic chronic pancreatitis.
Paraneoplastic Syndromes
Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes - connection with inflammation.
Parkinson Disease
Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.
Parkinson Disease
Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis.
Parkinson Disease
Association of Paraoxonse1 (PON1) Genotypes with the Activity of PON1 in Patients with Parkinson's Disease.
Parkinson Disease
Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure.
Parkinson Disease
Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease.
Parkinson Disease
Genetic polymorphism of paraoxonase 1 (PON1) and susceptibility to Parkinson's disease.
Parkinson Disease
Gln --> Arg 191 polymorphism of paraoxonase and Parkinson's disease.
Parkinson Disease
Identification of brain proteins that interact with 2-methylnorharman. An analog of the parkinsonian-inducing toxin, MPP+.
Parkinson Disease
No association between paraoxonase 1 (PON1) gene polymorphisms and susceptibility to Parkinson's disease in a Chinese population.
Parkinson Disease
Novel Redox-Dependent Esterase Activity (EC 3.1.1.2) for DJ-1: Implications for Parkinson's Disease.
Parkinson Disease
Paraoxonase 1 (PON1) gene polymorphisms and Parkinson's disease in a Finnish population.
Parkinson Disease
Paraoxonase 1 Met--Leu 54 polymorphism is associated with Parkinson's disease.
Parkinson Disease
Paraoxonase 1 polymorphisms L55M and Q192R were not risk factors for Parkinson's disease: a HuGE review and meta-analysis.
Parkinson Disease
Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's disease.
Parkinson Disease
Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease.
Parkinson Disease
Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
Parkinson Disease
Paraoxonase polymorphisms, pesticide exposure and Parkinson's disease in a Caucasian population.
Parkinson Disease
Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD-PD spectrum diseases.
Parkinson Disease
Pesticides exposure and genetic polymorphism of paraoxonase in the susceptibility of Parkinson's disease.
Parkinson Disease
Serological Profiles of Urate, Paraoxonase-1, Ferritin and Lipid in Parkinson's Disease: Changes Linked to Disease Progression.
Parkinson Disease
[Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease]
Pediatric Obesity
Favorable effect of short-term lifestyle intervention on human paraoxonase-1 activity and adipokine levels in childhood obesity.
Pediatric Obesity
Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels.
Pediatric Obesity
Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome.
Pediatric Obesity
Paraoxonase 1 activities and genetic variation in childhood obesity.
Periodontitis
Effects of paraoxonase 1 on the cytodifferentiation and mineralization of periodontal ligament cells.
Periodontitis
Potential Association of Paraoxonase 1, Type 2 Diabetes Mellitus and Periodontitis.
Peripheral Arterial Disease
No influence of increased intake of orange and blackcurrant juices and dietary amounts of vitamin E on paraoxonase-1 activity in patients with peripheral arterial disease.
Peripheral Arterial Disease
Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease.
Peripheral Nervous System Diseases
Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins.
Peritonitis
Role of paraoxonase-1 as a diagnostic marker for feline infectious peritonitis.
Peritonitis
Serum biomarkers of oxidative stress in cats with feline infectious peritonitis.
Persian Gulf Syndrome
Low paraoxonase in Persian Gulf War Veterans self-reporting Gulf War Syndrome.
Placenta Accreta
Decreased oxidative stress may contribute to the disease process in placenta accreta
Pneumonia
Zootechnical and health performance of Holstein x Gir crossbred calves.
Pneumonia
[Arylesterase activity and total serum esterolytic activity in infants with pneumonia]
Pneumoperitoneum
Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy.
Polycystic Ovary Syndrome
Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Association of Paraoxonase 1 Gene Polymorphisms and Polycystic Ovarian Syndrome Susceptibility: A Systematic Review and Meta-Analysis.
Polycystic Ovary Syndrome
Association of PON1 gene polymorphisms with polycystic ovarian syndrome risk: a meta-analysis of case-control studies.
Polycystic Ovary Syndrome
Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in Chinese women.
Polycystic Ovary Syndrome
Cardiovascular evaluation and serum paraoxonase-1 levels in adolescents with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction.
Polycystic Ovary Syndrome
Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome (PCOS) in south-west Chinese women.
Polycystic Ovary Syndrome
Lactonase activity and status of paraoxonase 1 in Chinese women with polycystic ovarian syndrome.
Polycystic Ovary Syndrome
Paraoxonase levels in women with polycystic ovary syndrome.
Polycystic Ovary Syndrome
Paraoxonase single nucleotide variants show associations with polycystic ovary syndrome: a meta-analysis.
Polycystic Ovary Syndrome
Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.
Polycystic Ovary Syndrome
PON1 polymorphisms are associated with polycystic ovary syndrome susceptibility, related traits, and PON1 activity in Indian women with the syndrome.
Polycystic Ovary Syndrome
PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenemia.
Polycystic Ovary Syndrome
Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.
Polycystic Ovary Syndrome
The association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome.
Polycystic Ovary Syndrome
The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.
Polycystic Ovary Syndrome
The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women.
Polycystic Ovary Syndrome
The role of proprotein convertase subtilisin/kexin type-9 concentration and paraoxonase 1 activities in the blood of women with polycystic ovary syndrome.
Polycystic Ovary Syndrome
[Combined analyses of paraoxonase-1 and IGF-2 polymorphism in polycystic ovary syndrome]
Polycystic Ovary Syndrome
[The -108 C/T polymorphism in paraoxonase 1 gene in Chinese patients with polycystic ovary syndrome].
Polyneuropathies
Bovine chromaffin cell cultures as model to study organophosporus neurotoxicity.
Polyneuropathies
The relevance of inhibitor-substrate interactions when measuring neuropathy target esterase inhibition.
Prader-Willi Syndrome
Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome.
Pre-Eclampsia
Association of L55M and Q192R Polymorphisms of Paraoxonase-1 Gene with Preeclampsia.
Pre-Eclampsia
Association of Midgestational Paraoxonase 1 Activity with Pregnancies Complicated by Preeclampsia.
Pre-Eclampsia
Association of paraoxonase 55 and 192 gene polymorphisms on serum homocysteine concentrations in preeclampsia.
Pre-Eclampsia
Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women.
Pre-Eclampsia
Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia.
Pre-Eclampsia
High-density lipoproteins (HDL) composition and function in preeclampsia.
Pre-Eclampsia
Oxidative stress markers in severe preeclampsia and preeclampsia-related perinatal morbidity - preliminary report.
Pre-Eclampsia
Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia.
Pre-Eclampsia
Paraoxonase and arylesterase activities in patients with preeclampsia.
Pre-Eclampsia
Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia.
Pre-Eclampsia
Placental ADAMTS-12 Levels in the Pathogenesis of Preeclampsia and Intrahepatic Cholestasis of Pregnancy.
Pre-Eclampsia
Serum levels of lipids, lipoproteins and paraoxonase activity in pre-eclampsia.
Prediabetic State
Potential Association of Paraoxonase 1, Type 2 Diabetes Mellitus and Periodontitis.
Prediabetic State
Serum Paraoxonase-1 Levels are Significantly Decreased in the Presence of Insulin Resistance.
Prediabetic State
Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A? in subjects with prediabetes.
Pregnancy Complications
Paraoxonase gene polymorphism and vitamin levels during pregnancy: Relationship with maternal oxidative stress and neonatal birthweights.
Premature Birth
Association of midgestation paraoxonase 1 activity and pregnancies complicated by preterm birth.
Premature Birth
Evaluation of Maternal Serum 25-Hydroxyvitamin D, Paraoxonase 1 Levels, and Neutrophil-to-Lymphocyte Ratio in Spontaneous Preterm Birth.
Presbycusis
The relationship between metabolic presbycusis and serum paraoxonase/arylesterase activity.
prostaglandin-endoperoxide synthase deficiency
A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.
Prostatic Hyperplasia
Increased Antioxidant Quality Versus Lower Quantity of High Density Lipoprotein in Benign Prostatic Hyperplasia.
Prostatic Hyperplasia
Lipid associated antioxidants: arylesterase and paraoxonase-1 in benign prostatic hyperplasia treatment-naïve patients.
Prostatic Neoplasms
A pilot study assessing the association between paraoxonase 1 gene polymorphism and prostate cancer.
Prostatic Neoplasms
An alternative pseudolikelihood method for multivariate random-effects meta-analysis.
Prostatic Neoplasms
Comparison of serum acetyl hydrolase (PAF-AH) and paraoxonase 1 (PON1) values between prostate cancer patients and a control group.
Prostatic Neoplasms
Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients.
Prostatic Neoplasms
New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.
Prostatic Neoplasms
Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.
Proteinuria
Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes.
Proteinuria
Clinical leishmaniosis in a captive Eurasian otter (Lutra lutra) in Spain: a case report.
Proteinuria
Increased HDL Size and Enhanced Apo A-I Catabolic Rates Are Associated With Doxorubicin-Induced Proteinuria in New Zealand White Rabbits.
Proteinuria
Lipid profile among girls with systemic lupus erythematosus.
Proteinuria
Serum ferritin and paraoxonase-1 in canine leishmaniosis.
Proteinuria
Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
Proteinuria
[Cholinesterase, arylesterase and proteinuria. A clinical trial in glomerular and tubular proteinuria (author's transl)]
Proteinuria
[Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?]
Pseudomonas Infections
Expression of PPAR? and Paraoxonase 2 Correlated with Pseudomonas aeruginosa Infection in Cystic Fibrosis.
Pseudomonas Infections
Identification and analysis of the salt tolerant property of AHL lactonase (AiiATSAWB ) of Bacillus species.
Psoriasis
Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function.
Psoriasis
Association of paraoxonase 1 (PON1) L55M and PON1 Q192R gene polymorphisms and risk of psoriasis.
Psoriasis
Biological anti-psoriatic therapy profoundly affects high-density lipoprotein function.
Psoriasis
Correlation between Lp(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1.
Psoriasis
Effect of the systemic use of methotrexate on the oxidative stress and paraoxonase enzyme in psoriasis patients.
Psoriasis
HDL associated paraoxonase-1 activity correlates with systemic inflammation, disease activity and cardiovascular risk factors in psoriatic disease.
Psoriasis
Paraoxonase (PON1) 55 polymorphism, lipid profiles and psoriasis.
Psoriasis
Paraoxonase-1 and other factors related to oxidative stress in psoriasis.
Psoriasis
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms.
Psoriasis
Plasma oxidation status and antioxidant capacity in psoriatic children.
Psoriasis
Psoriasis decreases the anti-oxidation and anti-inflammation properties of high-density lipoprotein.
Psoriasis
Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Psoriasis
Serum paraoxonase-1 activities and oxidative status in patients with plaque-type psoriasis with/without metabolic syndrome.
Psoriasis
The relationship between oxidative stress, smoking and the clinical severity of psoriasis.
Pulmonary Disease, Chronic Obstructive
Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD.
Pulmonary Disease, Chronic Obstructive
Authors' Reply: Evaluation of Paraoxonase 1 Activity in Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
Evaluation of Paraoxonase-1 Activity in Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
Evaluation of serum paraoxonase and arylesterase activities in subjects with asthma and chronic obstructive lung disease.
Pulmonary Disease, Chronic Obstructive
Identification of Prognostic Value of Rs3735590 Polymorphism in 3'-Untranslated Region (3'-UTR) of Paraoxonase 1 (PON-1) in Chronic Obstructive Pulmonary Disease Patients who Received Coronary Artery Bypass Grafting (CABG).
Pulmonary Disease, Chronic Obstructive
Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Paraoxonase Activity and Phenotype Distribution in Patients with Chronic Obstructive Pulmonary Disease.
Pulmonary Disease, Chronic Obstructive
Paraoxonase-1 gene in patients with chronic obstructive pulmonary disease investigation Q192R and L55M polymorphisms.
Pulmonary Disease, Chronic Obstructive
Paraoxonase-1 is associated with corneal endothelial cell alterations in patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Plasma protein thiols: an early marker of oxidative stress in asthma and chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
PON1 gene polymorphisms in patients with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Trace elements and oxidative stress in chronic obstructive pulmonary disease.
Pulmonary Embolism
The evaluation of two genetic polymorphisms of paraoxonase 1 in patients with pulmonary embolism.
Purpura
Effect of paraoxonase 1 gene polymorphisms on clinical course of Henoch-Schönlein purpura.
Pyometra
The plasma proteome and the acute phase protein response in canine pyometra.
Rectal Neoplasms
Identification of potential metabolic biomarkers of rectal cancer and of the effect of neoadjuvant radiochemotherapy.
Reflex, Abnormal
Prenatal organophosphate metabolite and organochlorine levels and performance on the Brazelton Neonatal Behavioral Assessment Scale in a multiethnic pregnancy cohort.
Renal Insufficiency
Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDL.
Renal Insufficiency
Decrease of serum paraoxonase activity in chronic renal failure.
Renal Insufficiency
Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
Renal Insufficiency
Effect of continuous renal-replacement therapy on paraoxonase-1-related variables in patients with acute renal failure caused by septic shock.
Renal Insufficiency
Paraoxonase (PON1) Gene Polymorphisms in Fabry Disease: Correlation with Renal Disease.
Renal Insufficiency
The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia.
Renal Insufficiency, Chronic
Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Renal Insufficiency, Chronic
Arylesterase activity but not PCSK9 levels is associated with chronic kidney disease in type 2 diabetes.
Renal Insufficiency, Chronic
Association of lipid profile with serum PON1 concentration in patients with chronic kidney disease.
Renal Insufficiency, Chronic
Comparison of serum paraoxonase and arylesterase activities between iron deficiency anemia patients and chronic kidney disease patients with anemia.
Renal Insufficiency, Chronic
Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease.
Renal Insufficiency, Chronic
Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease.
Renal Insufficiency, Chronic
Effect of nutritional status on human paraoxonase-1 activity in patients with chronic kidney disease.
Renal Insufficiency, Chronic
Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
Renal Insufficiency, Chronic
Enhanced Angiotensin II type 1 receptor expression in leukocytes of patients with chronic kidney disease.
Renal Insufficiency, Chronic
Genetic polymorphisms of paraoxonase-1 are associated with chronic kidney disease in Japanese women.
Renal Insufficiency, Chronic
Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease.
Renal Insufficiency, Chronic
Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients.
Renal Insufficiency, Chronic
Serum Endocan Levels are Associated With Paraoxonase 1 Concentration in Patients With Chronic Kidney Disease.
Renal Insufficiency, Chronic
Serum Paraoxonase Levels are Correlated with Impaired Aortic Functions in Patients with Chronic Kidney Disease.
Reperfusion Injury
Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3? RISK pathway.
Retinal Vein Occlusion
Molecular variant of the human paraoxonase/arylesterase gene is associated with central retinal vein occlusion in the Japanese population.
Retinal Vein Occlusion
Protective effect of paraoxonase 1 gene variant L55M in retinal vein occlusion.
Rheumatic Diseases
Relationship of paraoxonase-1, malondialdehyde and mean platelet volume with markers of atherosclerosis in familial Mediterranean fever: an observational study.
Rhinitis, Allergic
Plasma paraoxonase activity and oxidative stress and their relationship to disease severity in children with allergic rhinitis.
Rosacea
Decreased serum paraoxonase and arylesterase activities in patients with rosacea.
Sarcoidosis
Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Sarcoidosis
Levels of paraoxonase, an index of antioxidant defense, in patients with active sarcoidosis.
Schistosomiasis mansoni
Schistosoma mansoni: Effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel.
Scleroderma, Systemic
Plasma paraoxonase activity in patients with systemic sclerosis.
Seizures
Capsaicin Exerts Anti-convulsant and Neuroprotective Effects in Pentylenetetrazole-Induced Seizures.
Sepsis
Arylesterase Activity of HDL Associated Paraoxonase as a Potential Prognostic Marker in Patients With Sepsis and Septic Shock-A Prospective Pilot Study.
Sepsis
Cardiovascular Insufficiency, Abdominal Sepsis, and Patients' Age Are Associated with Decreased Paraoxonase-1 (PON1) Activity in Critically Ill Patients with Multiple Organ Dysfunction Syndrome (MODS).
Sepsis
Comparison of Protein Carbonyl (PCO), Paraoxonase-1 (PON1) and C-Reactive Protein (CRP) as Diagnostic and Prognostic Markers of Septic Inflammation in Dogs.
Sepsis
Decreased paraoxonase activity in critically ill patients with sepsis.
Sepsis
Early Elevation of Cell-free DNA After Acute Mesenteric Ischemia in Rats.
Sepsis
Effect of continuous renal-replacement therapy on paraoxonase-1-related variables in patients with acute renal failure caused by septic shock.
Sepsis
Effects of paraoxonase, arylesterase, ceruloplasmin, catalase, and myeloperoxidase activities on prognosis in pediatric patients with sepsis.
Sepsis
HDL Cholesterol Efflux is Impaired in Older Patients with Early Sepsis: A Subanalysis of a Prospective Pilot Study.
Sepsis
Identification of Protein Carbonyls (PCOs) in Canine Serum by Western Blot Technique and Preliminary Evaluation of PCO Concentration in Dogs With Systemic Inflammation.
Sepsis
Low paraoxonase 1 activity predicts mortality in surgical patients with sepsis.
Sepsis
Monocyte chemoattractant protein-1 and paraoxonase-1 and 3 levels in patients with sepsis treated in an intensive care unit: a preliminary report.
Sepsis
Paraoxonase 1 Activity and Survival in Sepsis Patients.
Sepsis
Prognostic value of serum paraoxonase and arylesterase activity in patients with sepsis.
Shock, Septic
Effect of continuous renal-replacement therapy on paraoxonase-1-related variables in patients with acute renal failure caused by septic shock.
Silicosis
[Serum myeloperoxidase activity and serum paraoxonase-1 activity in patients with silicosis and observation subjects and their clinical significance].
Sleep Apnea Syndromes
Oxidized-LDL and Paraoxonase-1 as biomarkers of Coronary Artery Disease in Patients with Sleep-Disordered Breathing.
Sleep Apnea, Obstructive
Letter to the editor: methodological approach to paraoxonase-1 activity in obesity complicated by obstructive sleep apnea.
Sleep Apnea, Obstructive
Paraoxonase 1 Gene L55M Polymorphism and Paraoxonase 1 Activity in Obstructive Sleep Apnea Patients.
Sleep Apnea, Obstructive
Reduced paraoxonase 1/arylesterase activity and its post-therapeutic increase in obstructive sleep apnea syndrome: a preliminary study.
Sleep Apnea, Obstructive
Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS).
Sleep Initiation and Maintenance Disorders
Serum paraoxonase, arylesterase activities and oxidative status in patients with insomnia.
Spasm
First survey of the three gene polymorphisms (PON1 Q192R, eNOS E298D and eNOS C-786T) potentially associated with coronary artery spasm in African populations and comparison with worldwide data.
Spasm
Ischemic heart disease as deficiency disease.
Spasm
Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm.
Spasm
Variant angina and coronary artery spasm: the clinical spectrum, pathophysiology, and management.
Specific Language Disorder
Reevaluation of Serum Arylesterase Activity in Neurodevelopmental Disorders.
Spinal Cord Injuries
Effects of prostaglandin E1, melatonin, and oxytetracycline on lipid peroxidation, antioxidant defense system, paraoxonase (PON1) activities, and homocysteine levels in an animal model of spinal cord injury.
Spinal Cord Injuries
Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury.
Spinal Dysraphism
Paraoxonase 1 polymorphisms and haplotypes and the risk for having offspring affected with spina bifida in Southeast Mexico.
Spondylitis, Ankylosing
Carotid intima-media thickness and paraoxonase activity in patients with ankylosing spondylitis.
Spondylitis, Ankylosing
Correlation of PON1 polymorphisms with ankylosing spondylitis susceptibility: A case-control study in Chinese Han population.
Spondylitis, Ankylosing
Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis.
Spondylitis, Ankylosing
Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients.
ST Elevation Myocardial Infarction
Association between paraoxonase 1 activity and severity of coronary artery disease in patients with acute coronary syndromes.
ST Elevation Myocardial Infarction
Oxidative Stress and Paraoxonase 1 Activity Predict Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
ST Elevation Myocardial Infarction
Paraoxonase-1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow.
Status Asthmaticus
Airborne particulate matter PM2.5 from Mexico City affects the generation of reactive oxygen species by blood neutrophils from asthmatics: an in vitro approach.
Status Epilepticus
Capsaicin Exerts Anti-convulsant and Neuroprotective Effects in Pentylenetetrazole-Induced Seizures.
Stomach Neoplasms
Association between paraoxonase-1 gene Q192R and L55M polymorphisms and risk of gastric cancer: A case-control study from Iran.
Stomach Neoplasms
The clinical and prognostic significance of paraoxonase-2 in gastric cancer patients: immunohistochemical analysis.
Stomach Neoplasms
The predictive role of Paraoxonase 1 (PON1) activity on survival in patients with metastatic and nonmetastatic gastric cancer.
Stomatitis, Aphthous
Serum prolidase and oxidative stress levels in patients with recurrent aphthous stomatitis: a prospective, controlled study.
Stomatitis, Aphthous
Total serum oxidant/antioxidant status and arylesterase activity in recurrent aphthous stomatitis.
Stroke
A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis.
Stroke
Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population.
Stroke
Apolipoprotein A-I and Paraoxonase-1 Are Potential Blood Biomarkers for Ischemic Stroke Diagnosis.
Stroke
Association between paraoxonase gene and stroke in the Han Chinese population.
Stroke
Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities.
Stroke
Epigenetic patterns of two gene promoters (TNF-? and PON) in stroke considering obesity condition and dietary intake.
Stroke
Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke.
Stroke
Lack of association between the paraoxonase 1 Q/R192 single nucleotide polymorphism and stroke in a Chinese cohort.
Stroke
Lipid peroxidation in stroke patients.
Stroke
Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population.
Stroke
MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms : three-year follow-up of the austrian stroke prevention study.
Stroke
Paraoxonase 1 (PON1) and stroke; the dilemma of genetic variation.
Stroke
Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk.
Stroke
Paraoxonase 1 in neurological disorders.
Stroke
Paraoxonase 2 gene C311S polymorphism is associated with a risk of large vessel disease stroke in a Polish population.
Stroke
Paraoxonase gene polymorphisms and haplotype analysis in a stroke population.
Stroke
Paraoxonase gene polymorphisms and stroke severity.
Stroke
Paraoxonase PON1 polymorphism leu-Met54 is associated with carotid atherosclerosis: results of the Austrian Stroke Prevention Study.
Stroke
Paraoxonase-1 polymorphisms and cerebral ischemic stroke: a pilot study in mexican patients.
Stroke
Paraoxonase-1 Q192R polymorphism is not associated with clopidogrel response in Chinese stroke patients.
Stroke
PON1 55/192 polymorphism, oxidative stress, type, prognosis and severity of stroke.
Stroke
Relationship between Paraoxonase 1 (PON1) gene polymorphisms and susceptibility of stroke: a meta-analysis.
Stroke
Study of the relationship between gene polymorphisms of paraoxonase 2 and stroke in a Chinese population.
Stroke
Systemic inflammation, endothelial dysfunction, dietary fatty acids and micronutrients as risk factors for stroke: a selective review.
Stroke
The paraoxonase gene polymorphism in stroke patients and lipid profile.
Stroke
[Relationship between single nucleotide polymorphisms of paraoxonase 2 and stroke]
Stroke
[The effect of cigarette smoking on serum activities of paraoxonase and arylesterase in stroke patients]
Stroke, Lacunar
Serum paraoxonase and arylesterase activities in patients with lacunar infarction: a case control study.
Systemic Vasculitis
PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
Takayasu Arteritis
Altered flow-mediated vasodilatation, low paraoxonase-1 activity, and abnormal high-density lipoprotein subclass distribution in Takayasu's arteritis.
Takayasu Arteritis
Homocysteine levels in takayasu arteritis -- a risk factor for arterial ischemic events.
Teratozoospermia
Oxidative stress and phenotype frequencies of paraoxonase-1 in teratozoospermia.
Thalassemia
Serum Paraoxonase Activity and Malondialdehyde Serum Levels Remain Unaffected in Response to Hydroxyurea Therapy in ?-Thalassemia Patients.
Thrombosis
Circulating Fibroblast Growth Factor-23 Level and Paraoxonase-1 Lactonase Activity in Chronic Hemodialysis Patients: Their Impact on the Incidence of Native AV Fistula Thrombosis.
Thrombosis
Ischemic heart disease as deficiency disease.
Thrombosis
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.
Thrombosis
Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population.
Thrombosis
Polymorphisms of the paraoxonase gene and risk of preterm delivery.
Thrombosis
The association of the PON1 Q192R polymorphism with complications and outcomes of pregnancy: findings from the British Women's Heart and Health cohort study.
Thyroid Cancer, Papillary
Paraoxonase and arylesterase activities in patients with papillary thyroid cancer.
Thyroid Diseases
Paraoxonase and arylesterase levels in autoimmune thyroid diseases.
Thyroid Neoplasms
Association between thyroid function and lipid profiles, apolipoproteins, and high-density lipoprotein function.
Thyroiditis
Increased paraoxonase and arylesterase activity in thyroiditis patients compared to healthy individuals: PS137.
Tinnitus
Paraoxonase Activity and Oxidative Status in Patients with Tinnitus.
Trauma, Nervous System
Three patients with probable aerotoxic syndrome.
Trichinellosis
Effect of cyclosporin A on trichinosis. A histochemical study.
Tuberculosis
PON1 activity and total oxidant status in patients with active pulmonary tuberculosis.
Tuberculosis
Serum paraoxonase and arylesterase activities in patients with pulmonary tuberculosis.
Tuberculosis, Pulmonary
PON1 activity and total oxidant status in patients with active pulmonary tuberculosis.
Tuberculosis, Pulmonary
Serum paraoxonase 1 activity and oxidative stress in pediatric patients with pulmonary tuberculosis.
Tuberculosis, Pulmonary
Serum paraoxonase and arylesterase activities in patients with pulmonary tuberculosis.
Uremia
Paraoxonase activity and paraoxonase 1 gene polymorphism in patients with uremia.
Uremia
PON-1 carbamylation is enhanced in HDL of uremia patients.
Uremia
Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
Urinary Bladder Neoplasms
Alterations of Antioxidant Enzymes and Biomarkers of Nitro-oxidative Stress in Tissues of Bladder Cancer.
Urinary Bladder Neoplasms
Diminished arylesterase enzyme activity and total thiol levels in bladder cancer patients.
Urinary Bladder Neoplasms
Paraoxonase and arylesterase activity in bladder cancer.
Urinary Bladder Neoplasms
Serum Paraoxonase-1 Concentration as a Potential Predictor of Urinary Bladder Cancer Recurrence. A Five Year Follow-Up Study.
Urolithiasis
Serum paraoxonase-1 gene polymorphism and enzyme activity in patients with urolithiasis.
Vascular Diseases
Accelerated atherosclerosis in rheumatoid arthritis.
Vascular Diseases
Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
Vascular Diseases
High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients.
Vascular Diseases
Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs.
Vascular Diseases
Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.
Vascular Diseases
Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.
Vascular Diseases
Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
Vascular Diseases
Paraoxonase-1 expression is up-regulated in Down syndrome fetal liver.
Vascular Diseases
Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Vascular Diseases
Postprandial modulation of serum paraoxonase activity and concentration in diabetic and non-diabetic subjects.
Vascular Diseases
Serum paraoxonase 1 (PON1) measurement: an update.
Vascular Diseases
TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease.
Vascular Diseases
The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status.
Vascular Diseases
The role of 'paraoxonase-1 activity' as an antioxidant in coronary artery diseases.
Vascular Malformations
GLYOXALASE I A111E, PARAOXONASE 1 Q192R AND L55M POLYMORPHISMS IN ITALIAN PATIENTS WITH SPORADIC CEREBRAL CAVERNOUS MALFORMATIONS: A PILOT STUDY.
Venous Thromboembolism
The Diagnostic Value of Oxidative/Antioxidative Balance Parameters in Venous Thromboembolism.
Virus Diseases
Genetic association of paraoxonase-1 polymorphisms and chronic hepatitis C virus infection.
Virus Diseases
Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities.
Virus Diseases
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection.
Vitamin B 12 Deficiency
Paraoxonase and arylesterase activities in adults with vitamin B12 deficiency.
Vitamin B 12 Deficiency
Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia.
Vitiligo
Reduced serum paraoxonase-1 levels in vitiligo: further evidence of oxidative stress.
White Coat Hypertension
Oxidative stress in white coat hypertension; role of paraoxonase.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3.1.1.2 arylesterase
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
